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ABSTRACT

Fried, Eva M. DNP. Miami Valley College of Nursing and Health, Wright State
University, 2014. LARCkit: A Toolkit to Increase Prescribing of Long Acting
Contraceptives to Adolescent and Young Women in a Public Health Setting
In an urban, publicly funded women’s health and family planning clinic, 56% of
pregnancies were reported to be unintended. The clinic director decided to address this
problem by focusing on providers’ contraceptive prescribing habits; especially
contraceptive prescribing for women aged 15-25. The purpose of the evidence-based
practice improvement (EBPI) project was to increase provider disclosure about longeracting reversible contraception (intrauterine and implantable methods known as “LARC”
methods). The goal of the EBPI project was to increase the percentage of contraceptive
prescriptions that are LARC methods for women aged 15-25 years. The clinical question
guiding the EBPI project was “Among healthcare providers in a public health clinic, how
does utilization of an evidence-based toolkit for providers, staff, and patients about long
acting reversible contraception (LARC), compared to no intervention, affect the
percentage of LARC prescriptions among all contraceptive prescriptions written for
women ages 15-25 over three months?” The intervention was a toolkit utilizing
components created and utilized by The Contraceptive Choice Project that had
demonstrated increased LARC prescribing and utilization in a similar Mid-western city.
The toolkit addressed specific prescribing barriers that were identified through an internal
survey and a literature search. The Evidence-Based Practice Improvement (EBPI)
iii

framework guided the EBPI project. This framework included rapid cycling in which the
intervention was regularly evaluated and adjusted with the goal of eventually realizing an
intervention that would sustain the goal of increasing LARC prescribing for women ages
15-25. The anticipated outcome was an increase in the percent of long-acting reversible
contraceptives out of all contraceptives prescribed. Because the patient population was
small overall, the EBPI project team decided to collect data on women of all ages, but to
separately calculate the EBPI project outcomes for women ages 15-25. The outcome was
an increase (from 6% to 20%) in LARC prescribing for patients’ ages 15-25, but a
decrease in LARC prescribing for patients older than age 26 (from 23% to 12.5%).
Changes in providers’ opinions were also measured with before and after surveys.
Findings from these surveys included an increase in consistency of language to describe
LARC methods, and recognition of the availability of LARC methods at the site.
Concerns about difficult method insertions and the side effect of unpredictable bleeding
persisted.
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I. INTRODUCTION
Despite the existence of effective contraceptive methods, half of all pregnancies in
the United States are unintended and 82% of pregnancies in 15-19 year old women are
unintended (Centers for Disease Control and Prevention [CDC], 2011a). In 2008, the last
year for which there is published data, 55% of all pregnancies in Ohio were unintended
(Kost & Henshaw, 2013). At a public health clinic serving low-income women in a
medium-sized, Mid-western city, 56% of all pregnancies were reported to be unintended
(Clinic Site Director, personal communication November 22, 2013). Unintended
pregnancies are associated with adverse maternal outcomes and neonates born as the
result of unintended pregnancies are more likely to be born prematurely and to have
negative physical and mental health effects (Guttmacher, 2013). Furthermore, there is a
cost burden related to unintended pregnancies. Taxpayer costs related to the medical care
associated with unintended pregnancy ranges between $9.6 and $12.6 billion per year
(Monea & Thomas, 2011). In addition, low-income women ages 15-25 have the highest
rates of unintended pregnancy (Finer & Zolna, 2014). When unintended pregnancy
occurs in adolescent women or women of lower socioeconomic status, unintended
pregnancies have the potential to further compromise opportunities for education and
employment.
Contraceptive Availability and Efficacy
There are existing methods of contraception that are more than 99% effective at
preventing pregnancy. These include sterilization, the contraceptive implant, and
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intrauterine contraception (IUC or IUD) (Hatcher et al., 2008). However, at the time of
unintended pregnancy as many as 45.4% of Ohio women report not using contraception
(CDC, 2011a). Contraception can prevent pregnancy by altering a woman’s fertility
and/or creating a barrier between sperm and egg. When any hormonal method is used
correctly and the woman does not experience gastrointestinal illness or medication
interactions, the rate of unintended pregnancy can be reduced to less than 0.05% per year.
In literature addressing contraceptive efficacy, the annual rate of unintended pregnancy
by method type is referred to as the method failure rate (Hatcher et al., 2008). Method
failure is further classified into perfect use failure rate and typical use failure rate. Perfect
use means that the woman or couple used the method exactly as prescribed without
delayed or missed doses, gastrointestinal illness, or interaction from another medication.
Typical use failure rates account for how the method is typically used in the context of a
woman’s life (Hatcher, et al., 2008).
Method Types
Short acting reversible contraceptive methods include the oral contraceptive pill
(OCP), patch, and vaginal ring. These methods require a woman to adhere to a dosing
schedule on a daily, weekly, or monthly basis. An injectable method, depo
medroxyprogesterone acetate (DMPA), requires an office visit for intramuscular injection
every 11-15 weeks, and can take longer to reverse than other contraceptive methods
(CDC, 2010). Long-acting reversible contraceptive methods (LARC), (intrauterine
methods and the single rod implant) on the other hand, require rare action on the part of
the user and their contraceptive effect ends with removal of the device. At the national
level, the OCP is the most commonly used contraceptive with 35% of female
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contraceptive users reporting this as their primary contraceptive method (The United
States Department of Health and Human Services [DHHS], 2011) (See Figure 1).
Unfortunately, OCPs are not the most effective method of preventing pregnancy.
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Figure 1. Percent of Female Contraceptive Use in the U.S. by Method Type. Percentages
per United States Department of Health and Human Services, 2011.

Method Efficacy
As displayed in Table 1, LARC methods have superior efficacy with typical use,
are more likely to be continued at one year, and can be cost effective when the initial cost
is divided by years of use and simply by preventing the costs associated with unintended
pregnancy. Because LARC methods eliminate user error as a component of efficacy, the
three LARC methods discussed here all have typical use efficacy rates of greater than
99% whereas DMPA has a typical use efficacy rate of 94%, the OCP, the patch, and the
ring have rates of 92%, and the male condom has a rate of 85% (see Table 1) (CDC,
2010; Hatcher, et al. 2008). The healthcare community supports the use of LARC as a
3

Table 1
Contraceptive Method Comparison
Type
Risks

Pill/patch/ring

Cardiovascular
complications

DMPA

Depression,
weight gain

Copper IUD

Infection, uterine
perforation

Levenogestrel
IUS

Infection, uterine
perforation

Single rod
implant

Depression,
Unscheduled
bleeding

No method

Benefits

Decreases
dysmenorrhea,
decreased
reproductive
cancers
Decreased
menstrual blood
loss
Efficacious
without
hormones
Decreases
menstrual blood
loss
Decreased
dysmenorrhea,
decreased
menstrual blood
loss

Higher risk of
unintended
pregnancy
(Hatcher, et al., 2008; Planned Parenthood, 2014

Perfect use Typical use
failure rate failure rate
0.3

9

Percent of women
continuing method at
1 year
67

0.2

6

56

$35-$100 per
3 months

0.6

0.8

78

0.2

0.2

80

$500-$1000
per 10+
years
$500-$1000
per 5+ years

0.05

0.05

84

$400-$800
per 3 years

85

85

Data not available

Zero initial
cost
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Cost

$15-$80 per
month

first choice method of contraception as evidenced by statements from the American College of
Obstetricians and Gynecologists (ACOG), The World Health Organization (WHO), and The
Centers for Disease Control and Prevention (CDC) (ACOG, 2011; CDC, 2010). Limiting the
availability of some methods of contraception is discouraged. As a national benchmark, Healthy
People 2020 initiative 3.1 has established the goal that all Title X funded clinics provide a full
range of contraceptive methods approved by the Food and Drug Administration (FDA) (DHHS,
2012). Title X clinics are federally funded programs dedicated to providing family planning
services to all Americans.
Cost
When viewed solely from a cost perspective, family-planning services save four dollars
in pregnancy related care for every dollar spent on contraception (DHHS, 2012). Cost to the
consumer is an evolving issue as the Affordable Care Act (ACA) purports to cover all
prescription contraceptive methods at no cost to the consumer (DHHS, 2014a). The reality of
implementing this coverage, however, remains unclear. Further, consideration of cost needs to
include long-term cost to the user and to society. The cost figures presented here do not address
the long-term financial sequelae for individuals and society that result from lost wages, deferred
education, and the perpetuation of poverty that can result from unintended pregnancy.
Background specific to the study site
To better understand the baseline prescribing patterns at the Midwestern urban public
health clinic where the EBPI project was implemented, all contraceptive prescriptions given for
women of all ages for the month of October 2013 (the most recent available baseline data at the
time) were reviewed and percentages of types of prescriptions written were calculated. The data
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revealed that OCPs were the most common contraceptive prescribed with 56% of patients using
the OCP method (See Fig. 2 and 3). The clinic exceeded the national average for LARC method
prescribing with LARC methods composing of 23% of all contraceptive prescriptions. However,
women aged 15-25 were only prescribed LARC methods 6% of the time. According to the clinic
director these numbers were consistent with overall contraceptive prescribing trends in the clinic
for the year prior to data analysis (Clinic Site Director, personal communication, November 21,
2013). While it is laudable that this clinic’s overall LARC prescribing exceeds the national
average, there remains significant room for improvement when only 6% of the clinic’s
contraceptive patients aged 15-25 are using the most efficacious methods and the site maintains
an unintended pregnancy rate of 56%.
Survey of Similar Sites
The clinic site director wanted to address the 56% unintended pregnancy rate at the
clinic. Because LARC methods have demonstrated to be the most effective methods of
contraception (Hatcher et al., 2008) the site director decided to attempt to lower the unintended
pregnancy rate by working first to increase the rate of LARC prescribing to patients of the clinic.
To this end, the site director partnered with the director of a community organization called
Council on Healthy Mothers and Babies (COHMAB) to discuss collaboration on a project to
reduce the rate of unintended pregnancy in the clinic site that may then be generalizable to other
public health settings in the community (Clinic Site Director, personal communication, January
13, 2013). The clinic site director and COHMAB director decided to conduct an assessment of
barriers to LARC prescribing in similar sites by administering a survey to groups of patients and
providers.

6

Method Type Ages 15-25

LARC 6%
Other 94%

Figure 2. October 2013 Contraceptive Prescriptions at EBPI project site for patients age 15-25
years. LARC-long acting reversible contraceptive

Method Type All Ages

LARC 23%
Other 77%

Figure 3. October 2013 Contraceptive Prescriptions at EBPI site for patients of all ages. LARClong acting reversible contraceptive
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The two site directors asked a doctor of nursing practice (DNP) student, who became the
EBPI project leader, to assist them in this process. Therefore, a team was formed for
conducting an internal quality improvement project that consisted of the site director, the
COHMAB director, and the DNP student. First the team developed two surveys, one for
healthcare providers and one for patients. The questions in each survey were not
validated; they came from the expert opinion and practical experience of members of the
team (See Appendix A). The goal of conducting the surveys were to determine the
accuracy of knowledge about LARC methods among providers and patients of public
health facilities in the area.
The COHMAB director posted provider surveys in an online anonymous format
to provider members of COHMAB. Notably, providers of the site where the doctoral
EBPI project eventually took place did not participate in this initial survey. COHMAB
member providers are those that provide women’s healthcare in local public health
settings. Fourteen providers were invited to participate and 5 surveys were completed.
Patient surveys were administered by paper and pencil to members of a group for new
mothers that were run by the COHMAB director. Four surveys were completed and
returned. Data collection took place in the Spring of 2013. It is not known whether the
four women who participated in the new mothers’ group were ever patients of the site
where the EBPI project eventually took place. Overall only four patient responses and
five provider responses were collected. Responses were then compiled and presented to
the COHMAB board by the COHMAB director and the DNP student (See Appendix B).
Findings from the Survey of Similar Sites
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Although the sample size was small, the themes that emerged were informative.
Patients thought of condoms as their primary contraceptive method and looked to their
providers for contraceptive advice. Even more revealing were the provider responses to
the question “Are there certain patients for whom you are more or less likely to discuss
long acting reversible methods?” Answers to this question revealed lack of knowledge
about the appropriateness of IUD use among young and/or nulliparous women, bleeding
expectations with IUDs, and biases against patients’ follow up care and questions
associated with the use of LARC methods. After these findings were presented to the
COHMAB board by the COHMAB director and the DNP student, attendees at the
COHMAB meeting noted that women looked to their providers for guidance regarding
contraceptive method choice and that providers had lingering misperceptions and biases
about LARCs in general and especially about never-pregnant adolescents as candidates
for LARC methods. After analysis of these limited findings, ultimately, the team charged
the current EBPI project leader (the DNP student) with the task of conducting a review of
literature to identify methods to improving the rate of LARC prescribing.
Guiding Framework
A framework was selected in order to guide literature appraisal and
implementation for a change in practice. The guiding framework was the EvidenceBased Practice Improvement (EBPI) model (Levin, et al., 2010). This framework was
chosen because it incorporates both evidence-based practice and quality improvement, or
program improvement methods. Evidence-based practice (EBP) integrates research
evidence with clinical expertise and patient preference (Melynk and Fineout-Overholt,
2011). According to the authors of the framework, EBP “provides a systematic
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framework for defining and focusing a clinical question” (Levin, et al., 2010, p. 117).
Quality Improvement (QI) is an ongoing process that uses rapid cycles to continually
appraise, alter, and effectively sustain an improvement (DHHS, 2014b). The EBPI model
was developed as a way to incorporate the systematic evidence gathering and appraisal of
evidence with a practical approach to application and sustainability of an effort that is
afforded by QI (Levin, et al., 2010).
Multiple QI models for rapid small tests of change were identified. The
implementation model incorporated in the EBPI framework is “Plan, do, study, act” or
“PDSA”. Plan, do, study, act is a formative evaluation process that includes frequent
feedback from stakeholders and the use of “small tests of change” before employing a
change on a large scale (Levin, et al., 2010, p. 123). This framework was an excellent fit
for the EBPI project because literature on the topic was collected and appraised using
evidence-based practice tools (Melnyk & Fineout-Overholt, 2011) and the information
obtained was combined with internal findings from geographically similar sites to create
a site-specific EBPI project. The PDSA cycles were an ideal component of the
framework because they allowed the site providers and staff to experiment with
modifying components of the intervention to find the best fit for the specific site. Step
one of the EBPI model is describing the clinical problem. The clinical problem the site
chose to address was the need to reduce the current rate of unintended pregnancy (56%)
reported by patients at the clinic by increasing prescribing of LARC methods.
PICOT Question
Initially, the clinical problem was formatted into a searchable question using the
PICOT format. PICOT (Patient population, Intervention, Comparison intervention,
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Outcome, Time) is a format for asking clinical questions that can help to focus a literature
search (Cochrane Collaboration, 2006). The question that guided the literature search
was “Among healthcare providers in a public health clinic, how does an intervention to
increase provider disclosure of long acting reversible contraception (LARC), compared to
no intervention, affect the percentage of LARC prescriptions among all contraceptive
prescriptions written for women ages 15-25 over three months?” Based on the literature
review a subsequent PICOT question was developed.
Purpose and Goals
The purpose of the EBPI project was to increase prescriber disclosure of LARC
methods as the most effective method of contraception. The goal of the EBPI project was
to increase the percentage of contraceptive prescriptions that were LARC methods. This
was an evidence-based practice change project. An evidence-based practice process was
used in which evidence was formally gathered, appraised, and synthesized to guide
practice improvement.
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II. EVIDENCE
Search Strategies and Results
Initial database searches using the terms “advanced practice nurse,” and
“adolescent” along with terminology about contraception produced very limited results.
Therefore, in order to gather as much information as possible the term “Long acting
contracep*” was entered in the Cochrane, CINAHL, and PubMed databases to capture
the key phrases “long acting contraceptive” and “long acting contraception”. Using this
term over 300 articles were identified. Thirty-six of those were deemed relevant from the
abstract and read in detail. Of the thirty-six, five were formally evaluated and kept in the
evidence synthesis (See Table 2). Additional hand gathering of articles was done after
reviewing articles referenced in the articles found in the key word searches. The search
terms were saved in PubMed and periodic updates from PubMed provided additional
articles that were utilized in the evaluation and synthesis of the most relevant literature.
These more recent articles did not suggest any changes beyond what was gathered
initially, they simply reinforced the need to change provider mindsets so that LARC is
seen as the best method of contraception for most women.
Inclusion and Exclusion Criteria
Initially the search was limited to articles published in the last 10 years, with
particular attention to articles published in the last five to six years. While multiple
articles from international sites were reviewed, ultimately, articles focusing on the United
States population were preferred as these focused on contraceptive methods specifically
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Table 2
Literature Search
Search
Keyword
Date
3/7/13
Long acting
contraceptive
3/7/13
Long acting
contracep*
3/7/13
Long acting
contracep*
Identified
Through
Long acting
PubMed
contracep*
updates

Database

# listed

# reviewed

# used

Cochrane

7

7

0

CINAHL

178

12

2

PubMed

152

3

2

PubMed

14

14

1

available in the United States. In summary, recent articles with larger sample sizes,
examining provider counseling in relation to contraceptive devices available in the
United States were kept in the final synthesis. Articles examining the cost effectiveness
of LARC methods were also retained. In addition, two sets of guidelines were reviewed
and included in the collection of external evidence (See Table 3).
Article Appraisal
Articles were appraised using a technique called “Rapid critical appraisal” as
defined by Melnyk and Fineout-Overholt (2011). This method includes evaluating each
article for level of evidence (described below), how the study was conducted (including
design, method, and possible confounding variables), and usefulness of study findings to
practice. Because the question addressed here was an intervention question, the evidence
was ranked (or leveled) as follows: Level 1; systematic reviews or meta-analyses of
randomized controlled trials, Level 2; randomized controlled trials; Level 3
nonrandomized controlled trials; Level 4 cohort or case-control studies; Level 5 Metasyntheses of qualitative or descriptive studies; Level 6 qualitative or descriptive single
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Table 3
Characteristics of Studies Included in Practice Recommendation
Citation
Rationale for Inclusion
Mestad, R., Secura, G., Allsworth, J.E., Madden,
T., Zhao, Q., & Peipert, J.F. (2011). Acceptance
of long-acting reversible contraceptive methods
by adolescent participants in the contraceptive
CHOICE project.

Large sample size, specifically
interested in adolescent
acceptance of, and choice among
LARC methods

Tyler, et. al. (2012). Health care provider attitudes
and practices related to intrauterine devices for
nulliparous women

Found healthcare provider
attitudes to be a barrier to LARC
provision

Deans, E. & Grimes, D. (2009). Intrauterine
devices for adolescents: A systematic review

Only broad systematic review
located, addressed provider
counseling as a variable

Kavanaugh, (2013). Meeting the contraceptive
needs of teens and young adults: Youth friendly
and long-acting reversible contraceptive services
in U.S. family planning facilities.

Teen and young adult population,
Large sample size
Provider counseling as a variable

Lewis, (2013). Intrauterine contraception: Impact
of provider training on participant knowledge and
provision.

Recent article,
Clinician training as variable

ACOG (2011) Guideline

Addresses LARC candidate
selection

USMEC (2010) Guideline

Addresses LARC candidate
selection

studies, and Level 7 expert opinion (Melnyk & Fineout-Overholt, 2011, p. 32).
Clinical Practice Guidelines
Two sets of guidelines were reviewed: The American College of Obstetricians
and Gynecologists (ACOG) practice bulletin on LARC (2011) and the U.S. Medical
Eligibility for Contraceptive Use (USMEC) (CDC, 2010). While neither set of guidelines
gave guidance specifically on provider disclosure, they did address the necessity of a shift
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in provider understanding about LARC usage and LARC candidate selection. Both
documents were reviewed using the rapid critical appraisal tool for guidelines (Melnyk &
Fineout-Overholt, 2011) (See Appendix C). The Committee on Practice BulletinsGynecology developed the ACOG guideline with assistance from two LARC experts.
Committee membership is not explicitly stated, so it is impossible to determine conflicts
of interest, but it is plausible that the committee was composed of ACOG members who
are all physicians and is, therefore, not an interdisciplinary group. The funding source
was also not specifically disclosed, but may be from membership dues. While the
recommendations made reference to numerous previous studies, no systematic method of
appraising the quality of the relevant literature was reported. It was not stated whether
the guideline had been subjected to peer review. The guideline recommendations were
clinically relevant and feasible, may lead to an increase in LARC prescribing and
provision, and outcomes could be measured by measuring changes in LARC prescribing.
The USMEC was adapted from the World Health Organization (WHO) Medical
Eligibility for Contraceptive Use (4th ed.) by the CDC’s Division of Reproductive Health.
The panel that adapted the WHO guidelines for specific U.S. use included “Eight key
partners and U.S. family planning experts” (CDC, 2010, p. 2). Only minor adaptations
were made to account for issues such as availability of certain methods in the U.S. The
panel conducted a systematic literature review for each recommendation considered for
adaptation using the United States Preventive Services Taskforce (USPSTF) system to
grade the evidence (USPSTF, 2014). Next the panel analyzed each systematic review.
After this, a larger meeting of 31 contraceptive experts from different specialties
convened to comment on the evidence presented. The guideline did not make explicit
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recommendations, but graded each contraceptive method on a safety scale for a number
of demographic and health criteria. The recommendations are clinically relevant and
assist in making direct patient care decisions about contraceptive eligibility. The
recommendations are practical and economically feasible. The recommendations could
trigger a variation from standard care particularly with regard to increased provision of
LARC methods due to a better understanding of patient eligibility for these methods.
Outcomes of this change in practice could then be measured. The ultimate
recommendation was to consider LARC as first choice methods for all women unless an
individual woman is deemed medically ineligible for a LARC method.
Findings from the Literature Review
Nationally, only 3.6 % of adolescents use IUDs (which are a LARC method) (DHHS,
2011). However, in one large study when education was provided and initial cost was
removed as a barrier, 60% of adolescent women chose LARC methods (Mestad, et al.,
2011). Further, Tyler and colleagues (2012) found that barriers to LARC provision
included; misconceptions about LARC associated with being a family medicine
specialist, not being trained in IUD insertion, and non-availability of IUDs on-site. Other
authors found that provider training was critical to increasing LARC provision and that
there is a positive association between rate of LARC provision and provider training in
“youth-friendly” contraceptive services (Deans & Grimes, 2009; Kavanaugh, et al., 2013;
Lewis, Darney, & Theil de Bocanegra, 2013; Mested, et al., 2011; Tyler et. al., 2012).
(See Table 4 for evaluation of the evidence retrieved from the literature search). The
evidence was assigned a level and rated for quality and usefulness to practice.
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Table 4
Evaluation of Literature

17

Citation,
funding, and
level of
evidence
Mestad, et al.,
(2011).
Acceptance of
long-acting
reversible
contraceptive
methods by
adolescent
participants in
the
contraceptive
CHOICE
project.

Design/ Method
Conceptual
Framework
Prospective,
observational
study evaluating
association
between age and
type of LARC
method chosen

Sample/Setting

Major
Variables

Measurement

Data
Analysis

Findings/Outcomes

5086 women
convenience
sample who
desired reversible
contraception for
at least one year.

IV 1: age

Questionnaire

When
controlling for
all covariates the
relative risk of
the younger
adolescents
choosing the
implant
remained
statistically
significant.

When education is
provided and initial
cost is removed as a
barrier, a majority of
adolescent women
choose LARC
methods.
Ages 14-17 are more
likely to choose the
implant while ages 1820 are more likely to
choose an IUD

DV: choice of
contraceptive
method

No conceptual
framework

Funding:
Multiple awards
and foundation
grants
LOE: IV

17

Quality of
Evidence:
Critical Worth to
Practice
Strengths: sample
size
Limitations:
convenience sample
Worth: significant
increase in percent
of women choosing
LARC compared to
national average.

Citation,
funding, and
level of
evidence
Tyler, et. al
(2012).
Health care
provider
attitudes and
practices related
to intrauterine
devices for
nulliparous
women
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Funding:
CDC
LOE: IV

Design/ Method
Conceptual
Framework
Design: survey
Purpose: to
“examine
prevalence and
predictors of
health care
provider
misconceptions
about the safety
of IUDs for
nulliparous
women”
No conceptual
framework
Descriptive
Study Design?

Sample/Setting

Major
Variables

Measurement

Data
Analysis

Findings/Outcomes

Quality of Evidence:
Critical Worth to
Practice

Random sample
4000 office
based and Title
X providers.
Response rates
were 44.9%77.5% dependent
on specialty
(primary care or
women’s health
specialty)
responses were
not sorted by
educational
background

DV 1: attitude
toward safety of
IUDs for
nulliparous
women
DV 2: provision
of IUD to
nulliparous
women

Questionnaire

Used
multivariable
logistic
regression to
estimate
adjusted odds
rations and
confidence
intervals of
associations
between patient,
healthcare
provider, and
clinical
variables and
provider
misconceptions
about IUD
safety and
provision in
nulliparous
women

Women’s access to
appropriate and
effective contraception
should not be limited
by provider
misconceptions and
lack of training.
Office –based
clinicians were more
likely than Title X
providers to view both
IUDs as unsafe for
nulliparous women,
Office based clinicians
were also less likely to
provide the copper
IUD to this group.
There was no
difference in provision
of levenogestrel IUD.
OB-GYN specialists
as well as providers
with IUD insertion
training and on-site
device availability
were also more likely
to have accurate
knowledge and
improved device
provision

Strengths: sample size,
consistent results
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Limitation: better
response rate from
Title X clinicians, not
certain how
respondents and nonrespondents differed,
unable to account for
other confounding
variables such as
insurance coverage
and other reasons for
patient preferences.
Worth:
Misconceptions
associated with being
a family medicine
specialist, not being
trained in IUD
insertion, and nonavailability of IUDs
on-site.

Citation,
funding, and
level of evidence
Deans, E. &
Grimes, D.
(2009).
Intrauterine
devices for
adolescents: A
systematic
review

Design/ Method
Conceptual
Framework
6 cohort studies
and 7 case series
included in
systematic
review

Sample/Setting

Major
Variables

Measurement

Data
Analysis

Findings/Outcomes

Systematic
review

DV 1:
continuation rate
DV 2: pregnancy
rate

Systematic
review

Multiple
methods due to
systematic
review

Adolescent
compliance is better
with long-acting
methods,
Insertion is
generally not
problematic,
concern for
association between
IUD provision and
tubal infertility is
unwarranted
Continuation rate
with IUD is similar
to or better than
with oral
contraceptives,
pregnancy rate
between methods is
similar at 2 years.
Expulsion may be
more likely in
younger women.

no conceptual
framework

Funding: not
disclosed
LOE: IV
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Quality of
Evidence:
Critical Worth to
Practice
Strengths:
systematic literature
search
Limitations: none of
the studies included
used IUDs currently
available in the
United States,
differences in
original studies
precluded a metaanalysis of the data,
selection bias in
original studies
Worth to practice:
Adolescent
compliance is better
with LARC, many
concerns about side
effects have been
allayed by recent
literature

Citation,
funding, and
level of evidence
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Kavanaugh,
M.L., Jerman, J.,
Ethier, K. &
Moskosky, S.
(2013). Meeting
the contraceptive
needs of teens
and young
adults: Youth
friendly and
long-acting
reversible
contraceptive
services in U.S.
family planning
facilities.

Design/ Method
Conceptual
Framework
Design
Conceptual
framework:
None

Sample/Setting

Major
Variables

Measurement

Data
Analysis

Findings/Outcomes

1,196 Publicly
funded facilities
in the U.S.

IV 2 Staff
training in
adolescentspecific
contraceptive
counseling

Questionnaire
sent to agency
directors or their
delegated staff
member

Chi-square
analysis

LARC methods
discussed less
frequently with
teens and young
adults than other
methods

DV 1 LARC
services

Quality of
Evidence:
Critical Worth to
Practice
Strengths:
Sample size
Limitations:
Self-report by clinic
directors
Findings may not be
generalizable to
privately funded
sites

Worth: provider
training is critical to
increasing LARC
provision. There is a
positive association
between rate of
LARC provision
and provider
training in “youthfriendly”
contraceptive
services

Funding
U.S. Dept. of
Health and
Human Services
Office of
Population
Affairs and The
Guttmacher
Institute
LOE: VI
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Citation,
funding, and
level of evidence
Lewis, C.,
Darney, P., &
Theil de
Bocanegra, H.
(2013).
Intrauterine
contraception:
Impact of
provider training
on participant
knowledge and
provision.
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Funding: State of
California,
Department of
Health Care
Services, Office
of Family
Planning

Design/ Method
Conceptual
Framework
Matched
comparison
No framework

Sample/Setting

249 clinicians
186 unique sites
Clinicians
(physicians and
“advanced
practice
clinicians”)
providing
contraceptive
care in the state
of California
who attended an
optional free
training about
intrauterine
contraception

Major
Variables

Measurement

DV: provision of
intrauterine
contraception
IV 1: training

Changes in
provider
knowledge and
attitudes using
Pre and post
training surveys

Data
Analysis

Findings/Outcomes

Claims match
analyses
Paired t-tests
Repeated
measures
analysis of
variance

Provision of
intrauterine
contraception
increased overall at
sites that sent
clinicians to
training.

Quality of
Evidence:
Critical Worth to
Practice
Worth to practice:
Skills-based training
can be an important
strategy for increased
provision of IC
Strengths:
Matched controls
Before and after
surveys
Limitations:
Primary care
clinicians are less
likely than WH
specialists to have
LARC. Increase in
LARC provision
after training may be
more significant in
this group.

LOE: IV

Study did not control
for other variables.
All claims from sites
sending a clinician to
training were used in
calculation, not just
claims specific to the
clinician who
attended the training.

CDC-Centers for Disease Control and Prevention, IC-intrauterine contraception, LARC- long-acting contraceptive, LOE- level of evidence,
MIDAS- Multinational Integrated Data Analysis System, SARC- short-acting contraceptive, UP-unintended pregnancy, WH-women’s health
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Evidence Synthesis
The evidence for the intervention used in this EBPI project was comprised of
cohort studies and expert opinion. Expert opinion generalized the scientific
understanding of the appropriateness of LARC methods as first line contraception to
adolescent and nulliparous women based on understanding of reproductive anatomy and
background literature establishing the safety and efficacy of LARC methods (Kavenaugh,
et al., 2013) (See Table 5). Findings from published literature suggest that barriers to
increasing LARC prescribing exist. Barriers include the initial higher cost, patient
misconceptions, and provider misconceptions, which can inhibit disclosure of all methods
(Cope, Yano, Lee, & Washington, 2006; Landry, Wei, & Frost, 2008; Lindberg, Frost,
Sten, & Dailard, 2006; Mested et al., 2011). All of the studies included found that
provider education might improve the frequency of LARC prescribing. Two studies
demonstrated that removal of cost as a barrier could improve the frequency of LARC
prescribing, and two studies found that consistency in message delivery to patients from
providers and staff could increase patient utilization of LARC.
Recommendation for Practice Change
The purpose of the EBPI project was to increase provider disclosure of LARC
methods. The recommendation for practice based on the literature review was to remove
provider barriers to prescribing LARC methods. Because provider barriers include; lack
of knowledge about LARC, inadequate patient teaching tools, inconsistency in LARC
messaging among providers and staff, and issues with reimbursement for LARC
methods, all of these were addressed in the practice change (ACOG, 2011; CDC, 2010;
Deans & Grimes, 2009; Mested, et al., 2011; Tyler, et al., 2012). The Contraceptive
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Table 5
Synthesis Table of Findings and Level of Evidence
Finding
Mested
Tyler

Deans

Kavanaugh

Lewis

X

X

X
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Provider education may
improve frequency of
LARC prescribing

X

Patient education is
important to increasing
LARC provision

X

Removing cost barriers
can increase LARC
provision

X

X

X

X

Consistency in message
delivery among staff
and providers can
increase LARC
provision
Use of a toolkit for
implementation

X

Level of Evidence

IV

X

IV

IV
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VI

IV

Choice Project in Saint Louis, Missouri, was found to have developed a toolkit to address
these concerns (Mested, et al., 2011). The Contraceptive Choice Project demonstrated a
significant increase in LARC utilization particularly among adolescent and young adult
women when providers were trained in LARC eligibility, provided consistency in LARC
message delivery, and all contraceptive methods were provided at no cost (Mested, et al.,
2011). Contraceptive Choice Project staff members were consulted regarding
implementing components of their project, and were forthright about limitations in
previous stages of implementation as well as their plans for future implementation. They
were supportive of the utilization of their program components in the current EBPI
project and helped guide selection of program tools to implement in the current EBPI
project setting (See Tables 6 and 7) (H. Broughton & S. Selbert, personal
communication, February 6, 2013).
Toolkit Approach
Because multiple barriers to LARC utilization were identified both in findings
from the literature search and internally at the EBPI project site, a toolkit approach was
selected to address many of these barriers at once. According to Butler (2007, p. 93) “A
toolkit is a set of materials-written documents, PowerPoint presentations, and other
resources- that support a particular practice or program,” and can be utilized to assemble
the best evidence on a topic into a comprehensive intervention. The Institute for
Healthcare Improvement (IHI) (2012) and The Agency for Healthcare Research and
Quality (AHRQ) (2011) have suggested the use of toolkits to address multiple barriers to
a practice change. Both organizations have authored numerous toolkits that translate
evidence into tools, trainings, and checklists that can be implemented in health care
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settings. Notably, The Contraceptive Choice Project (described above) used a toolkit
approach to provide structured contraceptive counseling and to remove cost barriers to
LARC (Mested, et al., 2011). To account for these factors a subsequent PICOT question
was created to guide the EBPI project: “Among healthcare providers in a public health
clinic, how does utilization of an evidence-based toolkit for providers, staff, and patients
about long acting reversible contraception (LARC), compared to no intervention, affect
the percentage of LARC prescriptions among all contraceptive prescriptions written for
women ages 15-25 over three months?”
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III. IMPLEMENTATION
Setting and Population
The EBPI project took place in an urban, publicly funded women’s health and
family planning clinic that was part of the city health department in a medium-sized Midwestern city. The population of the county served by the site was just over 1 million
people, 51.3% of whom are female. In addition the Caucasian, African American, and
Latino populations, there were refugee groups from Africa, the Middle East, and Asia
(Central Ohio Hospital Council, 2013). At the EBPI project site 37% of clients were of
Hispanic origin and 62% of clients spoke English as their first language. Language
interpretation was available via telephone, video conferencing, and face to face. The
population of focus for the clinic was women at 100% or below of the federal poverty
level. Patients who were uninsured or underinsured were seen for a donation or a fee
based on a sliding scale. The facility averages 130 patient encounters per month (Clinic
Site Director, personal communication March 12, 2014).
Evidence-Based Practice Improvement Project Approval
Agency permission was obtained from the public health clinic to conduct the
EBPI project. Human subject’s project approval was obtained from the institutional
review board at Wright State University (See Appendix D).
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Toolkit Components
LARC methods included in the toolkit were the copper IUD (brand name
Paragard), a progestin-containing IUD (brand name Mirena), and the progestin
contraceptive implant (brand name Nexplanon). A newer progestin-containing IUD
(brand name Skyla) was not included due to inconsistent product availability and
outcomes data at the time. The three LARC methods included in this EBPI project had
demonstrated increased efficacy over other contraceptive methods in a previous study
(Kavanaugh, et. al, 2013). The increased efficacy was attributed to reduction in both user
error and user discontinuation. Based on the success of The Contraceptive Choice Project
several of their toolkit components were included in this EBPI project. These included
an initial training (a 1.5 hour PowerPoint presentation and question/answer period) for
the clinic providers (three advanced practice nurses and one physician) as well as nurses
(one registered nurse (RN) and 2 licensed practical nurses (LPN) and staff (administrative
staff and medical assistants) (See Appendix E). Other toolkit components included from
The Contraceptive Choice Project included handouts for patients in both English and
Spanish, “scripting” to provide consistent message delivery among providers, and
resources to ensure adequate clinic reimbursement for contraceptive prescribing (See
Tables 6 and 7).
Barriers and Facilitators
An anticipated facilitator was support from the site director and the site’s medical
director. To maintain this support, the EBPI project leader provided clear timelines and
reports on the EBPI project. A second anticipated facilitator was that the clinic
maintained on-site availability of LARC methods due to receiving Title X funding (as
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described previously). Another anticipated facilitator was support from one of the
providers, a family nurse practitioner at the clinic who was motivated by her own
Table 6
Necessary Toolkit Components
Product/Document

Critical Components

Literature Support

Address specific provider
concerns about amount of
time necessary to educate
patients about insertion and
expected side-effects.
Literacy level
# of printed copies and
availability
Available in both English
and Spanish
Some graphics employed

Mested, et al. (2011)

Initial provider feedback
Time to present to providers,
plan for follow up
Ongoing provider feedback
and alterations as part of
PDSA cycling

Deans & Grimes
(2009), Kavanaugh et
al., (2013), Lewis et
al., (2013), Mested, et
al. (2011), Tyler et
al., (2012)

Scripting to ensure consistency Understandable for all clinic
in LARC message delivery
staff
Posted in all appropriate
places (front desk, billing,
medical assistant office,
provider office)

Kavanaugh et al.,
(2013), Mested, et al.
(2011)

Billing code sheet

Kavanaugh et al.,
(2013), Mested, et al.
(2011)

Patient teaching tools
(Method Fact Sheets)

Provider and staff education
(Initial training and Provider
resource notebook/LARC
provision guide)

Critical to implementation,
currently available at
practice
Readily available for billing
staff and providers
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Table 7
Toolkit Documents
Document(s)

Source

Medical eligibility criteria for
contraception

Centers for Disease Control and
Prevention

Choice project Findings

The Contraceptive Choice Project

Scripted response to IUD
commentary in the media

The Contraceptive Choice Project

Contraceptive counseling scripts The Contraceptive Choice Project
in English and Spanish
Contraceptive method fact
sheets

The Contraceptive Choice Project

Contraceptive method
frequently asked questions

The Contraceptive Choice Project

Helpful hints for LARC
insertions and removals

The Contraceptive Choice Project

LARC insertion timing
algorithms

The Contraceptive Choice Project

Menu of contraceptive options

The Contraceptive Choice Project

Method bridging protocol

The Contraceptive Choice Project

Signs of clinical urgency

The Contraceptive Choice Project

U.S. Selected practice
recommendations for
contraceptive use 2013 updates

Centers for Disease Control and
Prevention

LARC Quick Coding Guide

American College of Obstetricians
and Gynecologists

understanding of the current literature and her education to provide LARC methods as
first line contraception. This provider was educated more recently than the other two
providers and therefore may have been more aware of recent LARC recommendations
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and more likely to prescribe LARC methods on a more frequent basis. Table 8 shows
EBPI project facilitators and how each was addressed during implementation. The use of
rapid PDSA cycling was a facilitator as small tests of change offered the potential for
frequent modification of the toolkit based on staff and provider feedback.
Table 8
Facilitators
Facilitators

How addressed during implementation

Agency buy-in (support from site director
and medical director) Both presented the
EBPI project at related meetings within
the agency and invited the EBPI project
leader to speak about the EBPI project
whenever appropriate.

Voiced appreciation for teamwork and
provided clear timelines and progress
reports.

Site director also looked for connections
to other agency programs such as
providing contraception to patient’s of the
tuberculosis clinic.

Prioritized being present at different
agency meetings (birth outcomes,
reducing infant mortality) to educate
about the EBPI project

Title X funding
Healthy People 2020 has goal of “full
availability” of all FDA approved
contraceptive options at Title X funded
sites so the agency has a broader motive
to meet the goals of this EBPI project.

Remained current and knowledgeable
about this larger federal mandate and
addressed it at agency meetings

Grant in place with similar goal, which
further motivates site director and may
influence provider participation.

Keep meticulous records for site director’s
use

Anticipated barriers included variation in ethnicity and primary language (some
patients did not speak English) among patients at the site (See Table 9). To address the
Spanish language barrier, the clinic’s two full-time Spanish interpreters were involved in
the toolkit training. Other languages were anticipated to remain barriers to full
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implementation of the toolkit components. Another anticipated barrier was the potential
resistance of one provider at the site who expressed a bias against the follow up necessary
after prescribing LARC methods. In response to this provider’s initial concerns, teaching
tools were included in the toolkit that addressed common side effects and when to call the
clinic. To continue to engage this provider the EBPI project leader regularly solicited her
feedback and acted on it when appropriate.
Unanticipated barriers included lack of use of the toolkit by providers (other than
participation in the initial training) and lack of provider “buy-in” about the necessity for
change. Another unanticipated barrier was the absence of clinical and administrative
leadership from the site director and the medical director. Both of these individuals had
the opportunity to promote the EBPI project and to set goals and require adherence from
the providers. All three providers involved repeatedly reported that they already
promoted LARC methods prior to the EBPI project and did not need to change any
behaviors. These providers’ pre-EBPI project prescribing numbers suggest that they may
have already been promoting LARC, but still had room for improvement. While the
agency’s benchmarks and grant funding may have provided the site director with
motivation to increase LARC prescribing, it was not evident that she communicated this
to the providers. Instead, her advice to the EBPI project leader was to increase her
physical presence at the site. In effort to address this void in formal leadership, the
project leader did repeatedly increase her presence at the site.
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Table 9
Barriers
Barriers

Lack of use of toolkit
Lack of “buy-in” about necessity

How Barriers were addressed during
implementation
Frequent verbal conversations about tools and
posted some tools in prominent locations
Regular modifications to plan and feedback
about the EBPI project for change from

participants

Lack of formal leadership by
on site
Site director and Medical director

EBPI project leader greater physical presence

Language did not turn out to be a barrier because the medical director chose to
limit LARC communication to providers and registered nurses. Language interpretation
was available during these encounters. Cultural barriers were likely present, but were not
documented in the EBPI project and were not identified as barriers by providers or staff
in verbal discussions about the EBPI project’s progress. Interestingly, the EBPI project
participants did not mention time, a commonly cited barrier to counseling, as a barrier
either before or after the EBPI project implementation. Further, cost and method
availability, common barriers to LARC prescribing noted in the literature were not
barriers at the EBPI project site.
Implementation and Evaluation Plan
Step 6 of the EBPI model is engaging in tests of change. This is called plan, do,
study, act, or “PDSA.” During this phase the form developed by the Institute for
Healthcare Improvement was used to conduct periodic evaluations of the EBPI project
(See Appendix F). In this process “Plan” included making a prediction about what would
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happen and plan to test the change. “Do” included testing the change on a small scale
and documenting problems and unexpected observations. Provider and staff training, and
toolkit implementation began during the “study” phase. The “Act” stage included
altering the change based on the lessons learned and preparing for the next change cycle
(Institute for Healthcare Improvement, [IHI] 2014). This was accomplished using the
steps outlined in Table 10. A total of seven PDSA cycles were completed during the 12week EBPI project period (See Appendix G).
Data Collection and Outcomes
The clinic staff collected the data for the EBPI project. The EBPI project leader
(DNP student) was blinded to patient information. Staff members reviewed printed logs
of prescriptions that were organized by date and matched the contraceptive method
prescribed with the patient’s age. The EBPI project leader then categorized this in a
chart. The data were collected at the end of each of the three 4-week long periods of the
EBPI project and the EBPI project leader shared results with each individual provider.
After the first and second cycles of data collection, the team believed that DMPA was the
most commonly prescribed contraceptive method. It was only during the third data
collection cycle when the EBPI project leader identified that DMPA was being prescribed
at each visit (four times per year) rather than simply being prescribed once with refills.
Numbers of DMPA prescriptions were then recalculated using DMPA prescribed during
a visit with a provider rather than simply a DMPA prescription as criteria for being
counted in the analysis. Prior to this recalculation the EBPI project leader and
participants believed that DMPA was the most commonly prescribed contraceptive
method at the clinic.
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Table 10
PDSA Cycles
Cycle and Date

Action

1

1) LARC project site provider
opinion survey

4/21/14-4/28/14

2) Initial teachings
3) Toolkit introduction

34

2

1) Continue toolkit
implementation

4/28/14-5/11/14
2) Place key algorithms from
toolkit in prominent clinic
locations so clinicians do not need
to open toolkit to see algorithms.
3
5/11/14-5/18/14

1) Increase contact between EBPI
project leader and clinic contact
person by conducting in-person
site visit at least weekly and email
communication weekly

Findings

Thoughts for future

1) Response less enthusiastic than
anticipated
2) Medical director stated only licensed
personnel to be involved
3) Clinic in-service reiterated ideas
presented in in initial teaching
4) No participant use of toolkit after
initial teaching

May have given fewer tools
initially.

1) Clinic contact person (proposed
champion) stated team members “had
not had time” to look at toolkits
(binders) or to discuss them.

Clinicians will need additional
intervention to affect change.

1) Participants seem responsive to EBPI
project leader’s presence as evidenced
by their willingness to talk openly about
their prescribing practices when EBPI
project leader is present. However, all
participants confirmed they were not
using toolkit at all.

1) Clinicians will need
additional intervention to affect
change

34

2) One clinician revealed she
continues to refer to
contraceptive start algorithms on
reproductiveaccess.org.

EBPI Project leader to review
these.
Thoughts for future

Cycle and Date

Action

Findings

4

After checking that the content
was the same, EBPI project leader
posted LARC insertion algorithm
from reproductiveaccess.org in
provider work area with the intent
of increasing utilization of the
algorithm by preventing having to
look it up when needed.

Identified that LPNs and RNs were
administering DMPA injections (which
are administered every 12-15 weeks)
and therefore presented an opportunity
to counsel patients about LARC times
per year

Plan additional training for
LPNs and RNs to counsel about
LARC at DMPA injection visits.
Received approval from medical
director for this.

Plan to educate LPNs and RNs
about how to counsel about
LARC so they could do so at
DMPA injection visits

Only one individual available on day of
planned training.
This nurse was enthusiastic about
counseling.

Plan to train additional LPNs
and RNs in future weeks.

Share results (results %) and
observations from first 4 weeks of
EBPI project implementation and
illicit feedback from participants
on why they think changes were
made
Hoped this conversation would
encourage provider buy-in for the
remainder of the EBPI project.

Clinicians reported that they saw
minimal change in counseling and
prescribing habits because they believed
they were already counseling and
prescribing effectively. One clinician
did indicate that she had begun
counseling about LARC methods first.

5/19/14-5/26/14

5
5/26/14-6/8/14

35
6
6/9/14-6/29/14

35

Compile data from first 4 weeks
of the EBPI project

Cycle and Date

Action

Findings

Thoughts for future

7

1) Planned to compile data from
second 4 weeks of EBPI project to
see if positive prescribing trend
persisted and present to
participants

During data compilation EBPI project
leader realized that clinicians were
generating a new DMPA prescription
with every injection rather than
generating one prescription yearly with
refills. This realization led to a
significant re-examining of EBPI
project outcomes.
At the same time the clinic received
budget cuts that disrupted data
collection and limited participant
availability to meet with EBPI project
director.

In the last week of the EBPI
project overall project findings
were shared with each
participant and the LARC
project site provider opinion
survey was distributed in order
to compare responses with those
collected prior to the EBPI
project

6/30/14-7/13/14

36

DMPA-depo medroxyprogesterone acetate (depo provera), LPN- licensed practical nurse, RN-registered nurse
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Quantitative outcomes were evaluated by tracking the number and type of
prescriptions written over the three-month EBPI project period. The plan prior to
implementation was to collect information about how the toolkit components were used
through a written “parking lot” (a notebook in the clinic’s break room where providers
and staff could comment anonymously on the progress of the EBPI project) and
conversations with clinic providers and staff. Unexpectedly, the “parking lot” was never
utilized and repeated conversations and alterations to the PDSA cycles still resulted in no
use of the written materials in the toolkit by the providers or staff. Qualitative outcomes
were collected through conversations between the EBPI project leader and the clinic
providers and staff as well as through the LARC project site provider opinion survey that
was administered both before and after the EBPI project implementation.
There were seven PDSA cycles during the 12-week study period. Cycles were
intended to occur weekly, but unforeseen events such as personnel availability made this
impossible. In the first cycle the LARC project site provider opinion survey was
administered by providing the survey questions on paper to clinic providers. The surveys
were returned to a pile anonymously. The initial teaching was conducted (described
above) and the written toolkit (a collection of documents organized in a three ring binder
and distributed to each individual provider and work area) was introduced to the
participants. Responses were less enthusiastic than anticipated. After the initial teaching
very few questions were asked. When the EBPI project leader asked what components of
the toolkit attendees could picture themselves using one provider said “I just need time to
digest this,” and no one else responded. Another unanticipated barrier was that the
medical director stated after the initial teaching that he wanted the scripting portion of the
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toolkit limited to providers and nurses due to “medico-legal concerns.” A significant part
of the toolkit concept was to have consistency in message delivery from all individuals
that patients at the site might interact with. The EBPI project leader reiterated that the
goal was for no individual’s bias to create a barrier to the patient’s method choice.
Further, a required staff in-service for the entire facility, that the clinic is a part of,
included a presentation on adolescent health that reiterated the same themes presented in
the initial teaching. While this was positive in terms of reinforcing concepts, it also took
away the day that EBPI project participants had anticipated being able to review the
toolkit. The clinic liaison reported that no one had opened the binders during the first
week. The EBPI project leader’s initial reaction was that participants might have been
given too many resources at once. For cycle two the EBPI project leader and site director
decided to post keys (from the toolkit) in prominent locations around the clinic where
attendees would see them without having to open the toolkit (See Appendix H).
Specifically, algorithms were placed on the walls in provider offices and on the
medication sample closet (where providers would go to retrieve contraceptive methods).
At the end of cycle two participants reported that they still had not even opened the
binders. The EBPI project leader and the site director decided to try more “face time”
between the EBPI project leader and EBPI project participants as the next intervention.
This was based on the site director’s expert opinion having worked in a leadership role
with this particular group of clinicians.
For cycle three the EBPI project leader planned to visit the clinic at least once per
week and, in addition, to exchange email with the project liaison once per week. The site
director had identified an EBPI project liaison prior to beginning the EBPI project. This
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individual was chosen due to her interest in promoting change at the site as perceived by
the site director. During these visits and emails the EBPI project leader inquired about
the participants’ prescribing patterns and their use of the toolkits. Participants became
more talkative with the more frequent in-person visits during this cycle, but still not one
participant opened or utilized the written materials. An unexpected finding during this
cycle was that one clinician revealed she was consulting an algorithm for LARC insertion
from another source when she had questions about when to start a method. This clinician
stated she was more comfortable with this algorithm (compared to the ones in the toolkit
that were now also posted around the clinic) because she had already been using it and
that she looked it up online each time she wanted to access the LARC insertion
algorithm.
In response to the clinician who was using an algorithm from an outside source,
for the fourth cycle the algorithm in question was examined for accuracy and found to be
nearly identical to the algorithm in the implemented toolkit. Therefore, the EBPI project
leader printed copies of this algorithm and posted them alongside the toolkit algorithms
in the provider offices and on the door of the sample prescription closet. In person
conversations with participants during cycle four revealed that when patients presented
for DMPA injections (every 11-13 weeks) they were seen by a licensed practical nurse
(LPN) or registered nurse (RN) rather than a provider and therefore, if contraceptive
counseling was going to occur at these visits the LPNs and RNs would need additional
training in LARC counseling. Permission to provide this training was obtained from the
clinic’s medical director.
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For cycle five, additional training for LPNs and RNs in how to counsel about
LARCs was planned. This included information about determining appropriateness of
LARC methods for individual patients and scripting (from the toolkit) about the benefits
of LARC methods. Unfortunately, due to illness, only one nurse was available for
training during the planned time. This individual was very responsive to the discussion
of counseling about LARCs at DMPA injection visits and it was revealed that this
individual was not previously aware that a LARC method could be initiated before the
subsequent DMPA injection was due. Conversations with participants continued to
reveal that no participant had read or utilized any written component of the toolkitincluding the posted algorithms.
For the sixth cycle, data from the first four weeks of the EBPI were compiled and
evaluated. LARC prescribing for women ages 15-25 had increased from 6% to 18%.
Since findings were positive despite lack of use of the written components of the toolkit,
the EBPI project leader met with each participant individually to illicit feedback from
participants on why they thought prescribing changes had occurred. Clinicians responded
that they saw minimal change in counseling and prescribing habits because they believed
they were already counseling and prescribing effectively. One clinician did indicate that
she had begun counseling about LARC methods first. Again, each participant verified in
conversation with the EBPI project leader that she had not utilized the written toolkit
materials in any way and did not foresee him or herself doing so in the future. Other
providers responded verbally and by email that they did not know why a change was
noted, that they did not do anything to affect the change, and that it may have been due to
chance. Specific responses included the following: “I’m not sure why there has been a
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difference,” “Maybe everyone feels more comfortable discussing LARCs with our
patients since we received the education from you? Or maybe it’s a coincidence,” “It’s
hard to say, but it’s a good thing!” and “I think the only thing that has changed with my
practice is that when I list contraceptive options, I start with the LARCs and work my
way down. I used to start with the pills because that’s what most patients are most
familiar with.”
For cycle seven the plan was to compile and evaluate data from the second four
weeks of the EBPI project. During data compilation the EBPI project leader realized that
clinicians were generating a new DMPA prescription with every injection rather than
generating one prescription yearly with refills. Because data was being counted based on
the number of prescriptions generated for each method type, this was essentially
quadrupling the number of prescriptions for DMPA. The EBPI project leader and the
data collector reexamined the numbers, altering the criteria to reflect prescriptions
generated during a visit with a clinician only. At this point overall data for the entire
EBPI project period was shared with each participant. At the end of cycle seven
participants were once again congratulated for the positive change in prescribing for
women aged 15-25 and were asked to complete the LARC project site provider opinion
survey (identical to the one given before the initial teaching), again, on paper and
returned anonymously, in order to evaluate any changes in opinion about LARC methods.
Evaluation and Outcomes
The EBPI project leader identified several components to evaluate during the
EBPI project period. Initially, the number of LARC prescriptions as a percentage of
overall contraceptive prescriptions was recorded. This was done using the clinic’s
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electronic health record and was tallied by a staff nurse. The EBPI project leader
measured the frequency with which toolkit components were used by conducting
frequent informal conversations with and participants. Participant opinions were
measured by administering the same survey before and after the intervention (see Table
11).
Table 11
Evaluation and Outcomes
Evaluation component

Measurement approach and outcome

Number of LARC prescriptions written as
a percentage of overall contraceptive
prescriptions written during the study
period

*Electronic health record allowed for
tracking this measure. Nurse on clinic staff
tabulated prescriptions by prescription
type, month, and patient’s age.

Frequency with which toolkit components
were used

*Toolkit components were not used, other
than possibly algorithms that were posted.
Changes in provider counseling process
were determined through conversations
with individual participants.

How patient materials were utilized

Materials provided in toolkit were not
utilized

Participant opinion

Opinion surveys administered before and
after the intervention revealed few changes.
Most notably, one provider began
counseling about LARC methods at the
beginning of her contraceptive counseling
rather than at the end.
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IV. FINDINGS
Population Demographics
During the study period 42 women ages 15-25 received contraceptive
prescriptions as did 64 women ages 26 years and older for a total of 106 women. The site
primarily served women with incomes at or below 100% of the federal poverty level.
Data about language is not available for the study period, but in the most recent year that
data was collected at the site, 38% of women did not speak English as their primary
language or did not speak English at all (Clinic Site Director, personal communication
March 12, 2014).
Outcomes of the Evidence-Based Practice Improvement Project
Outcomes were tracked using the data collection tool (See Table 12). Prescribing
of LARC methods for women ages 15-25 increased over the course of the EBPI project
period from 6% to 20% of all contraceptive prescriptions written for this age group (See
Table 13). However, LARC prescribing in women 26 and older declined during the
EBPI project period from 30% to 18%. Prescribing outcomes were tracked by method
type (progestin IUD, copper IUD, contraceptive implant, DMPA, or contraceptive pills),
whether the method was a LARC or not (see Table 13), and by age group (15-25 years, or
26 years and older) (see Table 14). Clinic providers and staff did not utilize the toolkit as
expected. It is possible that interaction with the EBPI project leader was the only factor
in altering prescribing patterns. No one wrote in the parking lot. All clinicians stated
they were supportive of LARC prior to the EBPI project and that, therefore, their
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Table 12
Data Collection Tool
Oct. 1-Oct. 31
2013

April 21-May 18
2014

Number of prescriptions for contraceptive Implant in
women 15-25

1

2

Number of prescriptions for contraceptive Implant in
women 26 and older

3

1

Number of prescriptions for Progestin-containing IUS
in women 15-25

44

Number of prescriptions for Progestin-containing IUS
in women 26 and older

3

May 19-June 15 June 16-July 13
2014
2014
2

1

1

1

1

2

2

1

Number of prescriptions for copper IUD in women 1525
Number of prescriptions for copper IUD in women 26
and older

3

Number of prescriptions for DMPA in women 15-25

4

5

6

5

Number of prescriptions for DMPA in women 26 and
older

4

3

8

7

10
Ring: 1

8

6

3

Ring: 1

14

11

15

13

Number of prescriptions for OCP in women 15-25
Number of prescriptions for OCP in women 26 and
older

44

1

Table 13
Percentages of all Contraceptive Prescriptions that are LARC Methods by Patient Age
Oct. 1-Oct. 31 2013
April 21-May 18
2014

May 19-June 15
2014

June 16-July 13
2014

1/16=6%

3/17=18%

3/15=20%

2/10=20%

Percent of all contraceptive prescriptions that are
LARC methods in women 26 and older

9/27=30%

3/17=18%

2/25=8%

2/22=9%

Percent of all contraceptive prescriptions that are
LARC methods in all women

10/43=23%

6/34=18%

5/40=13%

4/32=12.5%

April 21-May 18
2014

May 19-June 15
2014

June 16-July 13
2014

45

Percent of all contraceptive prescriptions that are
LARC methods in women 15-25

Table 14
Number of Prescriptions by LARC vs. Other Methods by Patient Age
Oct. 1-Oct. 31 2013
Number of prescriptions for other contraceptive
methods in women 15-25

15

14

12

8

Number of prescriptions for other contraceptive
methods in women 26 and older

18

14

23

20

Number of prescriptions for LARC methods in
women 15-25

1

3

3

2

Number of prescriptions for LARC methods in
women 26 and older

9

3

2

2
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counseling had not changed. One exception to this was that one provider noted she had
begun counseling about LARC methods at the beginning of a contraceptive discussion
rather than at the end. The EBPI leader learned that at this site nurses attend ¾ of all
DMPA visits and that the initial understanding among the team about DMPA trends in
usage was inaccurate. There were no observations made about cultural variations in
LARC desire among patients.
Changes in provider opinion and attitude were measured qualitatively through
administration of the same LARC project site provider opinion survey before and after
the intervention (See Appendix A). Items that remained consistent both before and after
the EBPI project were: Concern about difficult device insertions and removals and
concern about patient complaints of unpredictable bleeding. Changes noted in the LARC
project site provider opinion survey that followed the intervention included: One provider
shifting from counseling about LARC in patients not wanting pregnancy for 1.5 years to
patients not wanting pregnancy for one year and one provider counseling about LARC at
the beginning of contraceptive counseling rather than at the end.
The question was “Among healthcare providers in a public health clinic, how
does utilization of an evidence-based toolkit for providers, staff, and patients about long
acting reversible contraception (LARC), compared to no intervention, affect the
percentage of LARC prescriptions among all contraceptive prescriptions written for
women ages 15-25 over three months.” The goal of the EBPI project was to increase the
percentage of contraceptive prescriptions that were LARC methods written for patients
aged 15-25. The goal was met with regard to these patients. LARC prescribing increased
from 6% to 20% for patients in this age group. Because the numbers of patients in this
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age group was small at the EBPI project site, the EBPI project was expanded to address
contraceptive prescribing for women aged 26 and older. The goal was not met with
patients aged 26 and older (See figures 4 and 5).

Method Type Ages 15-25

LARC 20%
Other 80%

Figure 4. July 2014 Contraceptive Prescriptions at EBPI project site for patients age 1525 years. LARC-long acting reversible contraceptive

Method Type ages 26 years and Older

LARC 18%
Other 82%

Figure 5. July 2014 Contraceptive Prescriptions at EBPI project site for patients of all
ages. LARC-long acting reversible contraceptive
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Economic outcomes
During the EBPI project period an additional two or three women aged 15-25
years received contraceptive methods that decreased their risk of pregnancy over the
ensuing year from 8% to less than 1%. If only one woman avoids an unintended
pregnancy due to this intervention a cost savings could be realized. According the
Guttmacher Institute (2011), unintended pregnancy costs U.S. taxpayers approximately
eleven billion dollars per year. If 60% of young women using contraception used the
most effective methods, as they did in The Contraceptive Choice Project, significant cost
savings could be realized. Laliberte and colleagues (2014) reiterated that provision of
any method of contraception, but especially LARC, is associated with significant cost
savings when compared to the cost of unintended pregnancy.
Findings from opinion surveys
The first question in the LARC project site provider opinion survey was “What
methods come to mind when you think of ‘long acting reversible contraceptives’
(sometimes called LARC methods)?” Prior to EBPI project implementation providers
listed correct responses but responses included a variety of brand names and varied
vocabulary about method type. After the EBPI project, answers to this question included
more streamlined terminology. Providers answered with only two terms “IUDs” and
“Nexplanon.”
The second question was “What are your initial thoughts when you hear the term
long acting reversible contraceptives?” Before the EBPI project implementation
providers mentioned efficacy and side effects in response to their initial thoughts
regarding LARC methods. After the EBPI project, one participant was better able to
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quantify the efficacy by stating that LARC methods are as effective as tubal ligation.
Both before and after the EBPI project it was mentioned that the term “LARC” is not
patient friendly. Of note, after the EBPI project, one participant responded to this
question with the concern that LARC methods can be “tricky to insert/remove.”
The third question was “Are there certain patients for whom you are more or less
likely to discuss long acting reversible methods?” This group of providers did not
express preference either before or after the EBPI project about which women were
appropriate candidates for LARC in terms of age or number of previous pregnancies.
Notably, prior to the EBPI project one respondent stated that she/he would not consider
LARC for a patient who wanted to avoid pregnancy for less than 1.5 years. After the
EBPI project there was also only one response regarding length of time the patient
desired to avoid pregnancy and that time it was one year.
The fourth question was “What are barriers to using these methods for you as a
practitioner?” Both before and after the EBPI project themes that emerged in response to
this question included patient misinformation as well as participant advantage to having
all of the LARC methods available on site. Prior to the EBPI project respondents
expressed concern about having had “several” difficult insertions and removals, the
bleeding profile with Nexplanon, cost, and the “invasiveness” of the methods. After the
EBPI project concerns included perceived patient lack of follow through with follow-up
visits and the mention of the “occasional” difficult insertion.
The fifth question was “What are some barriers in your practice for patients to
receive these methods?” Before the EBPI project answers included cost, personal bias,
appointment times, and patient fear of insertion or patient fear due to misinformation in
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the media. After the EBPI project one respondent exclaimed “very few!” while others
mentioned lack of back up for difficult insertions and insertion failure.
The sixth and final question was “What do you perceive as patient barriers to
use?” Prior to the EBPI project respondents mentioned stock (meaning having the
method(s) available on-site), patients needing multiple visits if pregnancy status could not
be determined, fear of pain, bleeding pattern, cost, and patient concern that the methods
were “too permanent.” After the EBPI project, responses to this question included the
invasiveness of the procedure, bleeding pattern, misperceptions about risks, and the
methods being “too long-term.”
Overall persistent themes included bleeding pattern, difficult insertions, and
patient misconceptions about risk and permanency of LARC methods. Changes noted
included a better understanding of LARC methods efficacy, consistency of language
among respondents about which methods are LARC methods. After the EBPI project no
respondents mentioned cost, appointment times, or method availability as barriers
possibly indicating their increased awareness that these barriers were not applicable at
their site.
Participants repeatedly reported that they never opened the toolkit. Interestingly
they did not read the section on difficult insertions though this continued to be a concern
for them throughout the EBPI project. Additionally, it is challenging to measure how
frequently participants looked at the posted algorithms or how their prescribing habits
may have changed based on conversations with the EBPI project leader. Findings are
extrapolated from what participants told the EBPI project leader and the changes noted in
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the LARC project site provider opinion surveys administered before and after the EBPI
project (See Table 15).
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Table 15
Responses to LARC Project Site Provider Opinion Survey
Question
Responses before EBPI project
implementation
What methods come to mind when you think
of “long acting reversible contraceptives”
(sometimes called LARC methods)?

Nexplanon, Mirena, Paragard, Skyla,

Responses after EBPI project
implementation
Nexplanon, IUDs (both)

Nexplanon, IUDs,
IUD, implants, injectables,
IUDs and nexplanon,
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What are your initial thoughts when you hear
the term long acting reversible contraceptives

Effective
Excellent methods for contraception.
Sometimes less desirable side effects
Efficacy, convenience, cost not a
patient/client friendly term

Are there certain patients for whom you are
more or less likely to discuss long acting
reversible methods?

More likely: pregnant patients,
teenagers, less likely: patients who
come in requesting shorter-acting
methods
More likely: women who will use
method for more than 1.5 years
Teenagers, multiparous
Discuss with everyone
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Efficacy and ease of use
Not a patient friendly phrase
Reliable, safe, can be tricky to
insert/remove
As effective as a tubal ligation

Not really-maybe if their personal
situation didn’t seem appropriate for
LARC, I guess.
Almost everyone, not someone who
wants a pregnancy in 1 year
No, I discuss them with all patients who
desire contraception

Question

What are barriers to using these methods for
you as a practitioner?

Responses before EBPI
implementation
Nexplanon’s bleeding profile makes me
wary, recently had several difficult IUD
removals which also makes me wary

Responses after EBPI project
implementation

Pt. fear of method/insertion, s/e profile

Misinformation that patients receive
from media, friends, etc.
Lack of patient follow-through
(sometimes patients don’t return for
visits)

Cost, education/myths/stigma,
invasiveness

We’re fortunate to have methods
available for uninsured

We are very fortunate to have all
methods available including for women
without insurance

Occasionally have difficulty with
insertion of IUD
I can’t think of any
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What are some barriers in your practice for
patients to receive these methods?

Scary, commercials about Mirena, cost,
hearing negative stories from family
and friends, fear of pain with insertion

Very few! We have LARCs available
any time and are, as a team, very proLARCs.

Sometimes stock

Maybe that we don’t have a lot of back
up for difficult insertions

Cost, personal bias

Not many-usually if they opt to not use

Limited appointment times (sometimes)

I am happy to insert any LARC, but
sometimes IUD insertion fails for
whatever reason, so after that failure
some patients may not want to try
again.
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Question

What do you perceive as patient barriers to
use?
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Responses before EBPI
implementation

Responses after EBPI project
implementation

Sometimes run out of Nexplanon, don’t
stock Skyla, patients come in with
recent unprotected sex and have to
return in 2 weeks for insertion

Having something “inserted” makes
patients nervous. Also, the varied
bleeding pattern of the Nexplanon turns
some patients off.

Fear of painful insertion, some think it
is “too permanent” even if they don’t
want pregnancy for several years,
partner dissatisfaction, s/e (bleeding)

Perceptions about risk or harm

Education, cost, lack of support

Fear/worry about side effects

Fear, misinformation, negative “word
of mouth” info, cultural bias

Seems “too long-term,” They don’t live
in a long-term world often

Lack of
education/knowledge/misconceptions

Mostly, the barriers to getting care at all
(transportation, child-care, life, etc.)
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V. DISCUSSION
Based on the results of the internal and external information gathered prior to the
EBPI project, the EBPI project leader believed that giving providers the tools to respond
to their concerns about LARC prescribing would result in an increase in LARC
prescriptions as a percentage of all contraceptive prescriptions. The EBPI project leader
also assumed that providers agreed that change was necessary and were motivated to
change their practice. The contribution to knowledge that stems from this EBPI project is
that, in addition to tools, resources, and leadership support, provider buy-in is necessary
for change to take place.
The purpose of the EBPI project was to increase provider disclosure of LARC
methods and the goal was to increase the percent of contraceptive prescriptions that were
LARC methods for women ages 15-25 years. In the original Contraceptive Choice
Project investigators found that 60% of adolescent women chose LARC methods when
cost, availability, and misinformation were removed as barriers (Mested, et al., 2011). In
this EBPI project, LARC prescribing increased from 6% to 20% of all contraceptive
prescriptions for women aged 15-25. Notably, the actual numbers of patients mean that
results are unlikely to have reached statistical significance and could have been due to
chance or to other variables. In The Contraceptive Choice Project, trained contraceptive
counselors used scripted materials to counsel about LARC and other methods and
reported the patient’s chosen method to the physician or nurse practitioner. In this EBPI
project, the same scripting was made available to the healthcare providers, but they

55

elected not to use it. In The Choice Project, all staff was trained in LARC messaging to
ensure message consistency to patients. In this EBPI project all staff was present for the
initial training, but unlicensed personnel where prohibited from communicating with
patients about the patient’s choice of contraceptive method. Notably, in this EBPI
project, there was not always a clinician on-site who could assist with challenging LARC
insertions. It is possible to infer that because The Contraceptive Choice Project was a
research project, all clinicians in that project had “buy-in” and felt competent performing
LARC insertions. Therefore fear of insertion difficulty or failure likely played less of a
part in clinician decision making in that project. In both The Choice Project and this
EBPI project, all methods of contraception were available the day of the initial visit as
cost was not a barrier. Limitations in this EBPI project included the small sample size and
the limited time frame of the intervention.
Dissemination of Findings
Step 7 of the EBPI model is “Disseminate best practices.” The EBPI project
leader and site director plan to present findings from the project at the annual project fair
at the Ohio Nurses Association and at the annual state of Ohio gathering of Certified
Nurse Midwives. Further, findings from the EBPI project may be implemented in other
clinics run by the same public health facility as well as other local clinics receiving Title
X funding. Finally, the EBPI project leader plans to present findings to her APRN
students in order to affect change at their practice sites. Stakeholders included patients
and their families, the clinic staff and providers, and the public health organization that
includes the clinic. Stakeholders in dissemination include any clinicians who can learn
from the project and their future patients. Individuals directly involved in the EBPI
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project, in addition to the EBPI project leader, included the clinic director, the three
advanced practice nurses at the site, the medical director, and the clinic staff.
Future Recommendations & Conclusion
Because the problem of unintended pregnancy persists and major professional
organizations support increased LARC prescribing as one method of addressing the
problem, this project cannot be abandoned. Recommendations for the future include
surveying providers prior to implementation of any project to assess whether providers
perceive that change is necessary. Second, a recommendation for the future is for
leadership to clearly communicate a goal and a strategy for reaching that goal when a
change is desired. In this EBPI project providers were given tools and resources but not
required to use them. Finally, it might be helpful to utilize a change theory in addition to
the EBPI model in order to identify and address barriers to change present that may
prevent full implementation of the project.
Strength in the implementation of this EBPI project was the use of the PDSA
model. When it was discovered that the written portion of the toolkit was not being used,
it was important to identify an intervention that might be more effective. A thought for
the future would be to verbally address each concern with participants as it arose. For
example, the EBPI project leader could provide training on what to do to make IUD
insertions less difficult or could review charts to identify missed opportunities for use of
the toolkit components. Participants may be more responsive to practical application of
components of the tool kit rather than access to a written description of a protocol.
However, if they do not buy-in to the idea that change is necessary it is unclear that any
intervention would work.
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An additional limitation of the EBPI project was that site leadership did not set
expectations for follow through on use of the toolkit components. The ideal next step
would be to continue the EBPI project at the same site with modifications to assess
provider buy-in and leadership requirement of available tools and resources. Another
possible addition would be to trigger providers with a pop up message in the electronic
health record recommending LARC whenever a contraceptive prescription was ordered.
Summary
According to Guttmacher Institute (2013) American women spend an average of
30 years avoiding pregnancy. Increasing provider disclosure of LARC methods is
critical, as LARC methods have been shown to reduce the rates of user error and
unintended pregnancy, particularly among adolescent and young women. Therefore, it is
the ethical duty of all providers who care for women to educate their patients about the
full range of contraceptive options and to work toward full availability of these options
for women of all ages and socioeconomic groups. When healthcare facilities that serve
low-income women fail to provide access to and advocacy for LARC, this population
remains unnecessarily vulnerable to unintended pregnancy. Additional pregnancies and
children place a disproportionate burden on impoverished women, further limiting their
access to education and employment and often keeping them in unhealthy relationships
(DHHS, 2012a).
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Appendix A
Patient and Provider Surveys
PATIENT SURVEY
1) What kinds of birth control are you aware of?
2) What type of birth control would you recommend to a friend?
3) What myths or rumors have you heard about certain types of birth control?
4) If you could have any kind of birth control you wanted for free, what would you
want?
5) If your doctor (or other healthcare provider) recommended a long-term form of
birth control, what would you think?

PROVIDER SURVEY
What methods come to mind when you think of “long acting reversible contraceptives”
(sometimes called LARC methods)?

1) What are your initial thoughts when you hear the term long acting reversible
contraceptives
2) Are there certain patients for whom you are more or less likely to discuss long
acting reversible methods?
3) What are barriers to using these methods for you as a practitioner?
4) What are some barriers in your practice for patients to receive these methods?
5) What do you perceive as patient barriers to use?
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Appendix B
Patient Survey Results from COHMAB project
And
Provider Survey Results from COHMAB project
LARC COHMAB PATIENT SURVEY
6) What kinds of birth control are you aware of?
pill
4
condoms
4
shot
2
IUD/Mirena
2
Nuvaring
1
patch
1
7) What type of birth control would you recommend to a friend?
condom
patch
pill
Talk to your doctor

3
1
2
2

8) What myths or rumors have you heard about certain types of birth control?
IUDs
“Could still get pregnant and it could hurt the baby”
Cause infection
Change period
“IUDs fall out and hurt”
hair falls out
Negative Mirena adds on TV
Other
Cancer from pills
Not 100% effective
Bruising from Nexplanon
Sex feels better without birth control
Pills make you gain weight
9) If you could have any kind of birth control you wanted for free, what would you want?
Condoms
2
Mirena
1
1 additional respondent said “something like an IUD, but one that doesn’t hurt”
10) If your doctor (or other healthcare provider) recommended a long-term form of birth
control, what would you think?
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“Not natural”
“Don’t like things in my body”
“Would think about it, but only after having children”
“Would appreciate the information”

Provider Survey Results from COHMAB project
LARC COHMAB PROVIDER SURVEY
5 Respondents
1) What methods come to mind when you think of “long acting reversible contraceptives”
(sometimes called LARC methods)?
IUD
3
Mirena
4
Paragard
2
Nexplanon/implanon/implant
4
2) What are your initial thoughts when you hear the term long acting reversible
contraceptives
Good choice for many clients
Multiple options, good methods typically
Wise & Responsible Decision
Wonderful I know a lot of women who would benefit from this form of contraceptive;
however, cost could be a factor
More patients should use them
3) Are there certain patients for whom you are more or less likely to discuss long acting
reversible methods?
I discuss a reproductive plan with all clients
IUD/Paragard: - less likely- patients with no children whom want children in the future more likely older patients 40+ whom are high risk in regards to OB, to prevent
pregnancy, women whom are done having children but not 100% sure Implant more
likely- teenagers, young adults in college
Yes
NO, however woman without insurance may not be able to afford these methods
Ones who seem very intolerant of bleeding
4) What are barriers to using these methods for you as a practitioner?
N/A
Mirena/Paragard: $$$ for private patients based on deductible/copay/etc...
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Our Clinic is a Prenatal Clinic only. We do not give birth control but we can discuss
options and provide them with community resources to receive the birth control of
choice.
Cost Some cultural concerns for the patient
None

5) What are some barriers in your practice for patients to receive these methods?
N/A
none- several physician do these procedures
False information from parents and grandparents. Patients may also experience Insurance
problems.
Cost Site of mobile, cannot provide direct services, however, can refer to our hospital site
clinics.
patients not having insurance, but being outside the parameters of LARC eligibility
6) What do you perceive as patient barriers to use?
Concerns about side affects
side effects, risk for perforation (IUD/Paragard), irregular periods, what they hear from
friends and family
Not being responsible and false information received from family members.
Cost Fear of not getting pregnant again
Bleeding and cramping that they will experience. Even when you educate, they call and
complain, often wanting the device removed.

67

Appendix C
Rapid Critical Appraisal Tool

Print & Use to Rapidly Critically Appraise Evidence-based Clinical Practice Guidelines
CREDIBILITY
1.
2.

Who were the guideline developers?
Were the developers representative of key stakeholders
in this specialty (interdisciplinary)?

3.
4.

________________________
Yes

No

Unknown

Who funded the guideline development?
Were any of the guideline developers funded researchers
of the reviewed studies
5. Did the team have a valid development strategy?
6. Was an explicit (how decisions were made), sensible and
impartial process used to identify, select and combine
evidence?
7. Did its developers carry out a comprehensive, reproducible
literature review within the past 12 months of its publication/
revision?
8. Were all important options and outcomes considered?
9. Is each recommendation in the guideline tagged by the level/
strength of evidence upon which it is based and linked
with the scientific evidence?
10. Do the guidelines make explicit recommendations (reflecting
value judgments about outcomes)?

_______________________

11. Has the guideline been subjected to peer review and testing?
APPLICABILITY/GENERALIZABILITY
12. Is the intent of use provided (e.g. national, regional, local)?
13. Are the recommendations clinically relevant?
14. Will the recommendations help me in caring for my patients?
15. Are the recommendations practical/feasible
(e.g. resources [people and equipment] available?
16. Are the recommendations a major variation from current practice?
17. Can the outcomes be measured through standard care?

Yes
Yes

No
No

Unknown
Unknown

Yes

No

Unknown

Yes
Yes

No
No

Unknown
Unknown

Yes

No

Unknown

Yes

No

Unknown

Yes

No

Unknown

Yes
Yes
Yes

No
No
No

Unknown
Unknown
Unknown

Yes
Yes
Yes

No
No
No

Unknown
Unknown
Unknown

Modified from Shutsky, J. (2005). Using Evidence-based Guidelines: Tools for Improving Practice. In B.M. Melynk & E. Fineout-Overholt (Eds). Evidence-Based
Practice in Nursing & Healthcare. A Guide to Best Practice (pp. 221-236). Philadelphia: Lippincott, Williams, & Wilkins.
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Appendix D
Agency Approval
And
Wright State University IRB Approval

“Available upon request from project author.”
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Appendix E
Teaching Plan
Objectives:
Recall the rate of unintended pregnancy nationally
State the most effective forms of contraception
State factors that have been demonstrated to increase LARC method disclosure by
providers
State resources for LARC prescribing questions including The Choice Project algorithms
and the USMEC
Content:






Clinical Issues
1) Unintended pregnancy
2) LARC utilization
The Problem
Half of all pregnancies in the U.S. are unintended (of these almost half are due to
incorrect contraceptive use)
 82% of teen pregnancies are unintended
 LARC Methods
 Contraceptive Methods
 Current Contraceptive Use
 The Problem
Long-Acting Reversible Contraceptives (LARC) including IUDs and the contraceptive
implant are much more effective than pills at preventing unintended pregnancy but are
underutilized.
 Benchmarks
 Healthy People 2020 advocates for all title X funded clinics providing the full
range of FDA approved contraceptives
 Barriers to increasing LARC use
 Current literature demonstrates that clinician misunderstanding can be a barrier to
full LARC prescribing
 Literature Continued
 PatientsLook to providers for contraceptive advice
 ProvidersHave misconceptions about eligibility criteria for LARC methods
Findings
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 Teens who heard of IUDs from a healthcare provider were almost 3x as likely to
be interested in using them
 Conclusion
Provider education is important to increasing LARC utilization
 CDC guidelines (endorsed by ACOG)
 Features of a LARC friendly practice
 All women, including teens, are presumed to be good LARC candidates until a
medical history indicates otherwise.
 Staff are trained to accurately respond to common LARC patient questions and
concerns to encourage continuation and satisfaction.
 LARC is always discussed as the first-line option for all women, including teens.
 What are we doing at CPH?
 CPH LARC utilization
 Organizational goals
 Facilitators
 The Next Step…
One project was identified in the literature that has an existing set of interventions to
increase LARC prescribing.
The Contraceptive Choice Project includes:
*Provider and staff training tools to address barriers to disclosure
*Scripted patient education to improve consistency in message delivery
 The Next Step…
 American College of OB/GYN (ACOG) has existing billing and coding tool
 CDC has existing medical eligibility criteria tool
 Choice Project LARC Insertion Algorithm
 Intervention and Evaluation
 Intervention: LARCkit (provider resource notebook)
 Goal: Increase the percentage of contraceptive prescriptions that are LARC
methods
 Weekly Evaluations
 So What?
 When healthcare facilities that serve low-income adolescent and young adult
women fail to provide full disclosure of LARC methods, this population remains
unnecessarily vulnerable to unintended pregnancy
 What do you know about cost?
 Pathway to Choice Video

71

Appendix F
Institute for Healthcare Improvement PDSA Tool

Science of Improvement: Testing Changes
Once a team has set an aim, established its membership, and developed measures to determine
whether a change leads to an improvement, the next step is to test a change in the real work
setting. The Plan-Do-Study-Act (PDSA) cycle is shorthand for testing a change — by planning it,
trying it, observing the results, and acting on what is learned. This is the scientific method, used
for action-oriented learning.
See also: Tips for Testing Changes, Linking Tests of Change, Testing Multiple Changes,
Implementing Changes, Spreading Changes.

Reasons to Test Changes
To increase your belief that the change will result in improvement.
To decide which of several proposed changes will lead to the desired
improvement.
To evaluate how much improvement can be expected from the change.
To decide whether the proposed change will work in the actual
environment of interest.
To decide which combinations of changes will have the desired effects on
the important measures of quality.
To evaluate costs, social impact, and side effects from a proposed change.
To minimize resistance upon implementation.
Steps in the PDSA Cycle
Step 1: Plan
Plan the test or observation, including a plan for collecting data.
State the objective of the test.
Make predictions about what will happen and why.
Develop a plan to test the change. (Who? What? When? Where? What
data need to be collected?)
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Step 2: Do
Try out the test on a small scale.
Carry out the test.
Document problems and unexpected observations.
Begin analysis of the data.
Step 3: Study
Set aside time to analyze the data and study the results.
Complete the analysis of the data.
Compare the data to your predictions.
Summarize and reflect on what was learned.
Step 4: Act
Refine the change, based on what was learned from the test.
Determine what modifications should be made.
Prepare a plan for the next test.
© 2014 Institute for Healthcare Improvement. All rights reserved
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Appendix G
PDSA Cycles 1-7
PDSA WORKSHEET
Date of test: 4/21/14Team/project:
4/27/14

Cycle: 1

Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers

Test population: Same

What is the objective of the test?
Note who is using scripting and what other tools are used and when

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
LARC project site provider opinion survey administered to participants
Initial education and introduction of toolkit to providers and staff
How will you know that the change is an improvement?
Provider and staff feedback initially, a change in % of LARC prescriptions overall
What driver does the change impact?
Provider disclosure of LARC methods
What do you predict will happen?
Initial resistance to “anything new.” May find that disclosure changes as a result of introductory session,
new resources, peer and leadership pressure to favor LARC methods
Plan for change or test: who, what, when, where (use back for more detail)
1.5 hour meeting with all providers and staff at clinic site. Introductory presentation outlining the problem
and the approach to change, introduction to how to use the toolkit and answer all questions.

74

PLAN
Test start date:

Target test completion date:

List the tasks necessary to complete this
test (what)
1. PowerPoint presentation prepared and
delivered

Person
responsible
(who)
EBPI project
leader

2. Binders prepared and delivered
3. Site director and medical director present
and united regarding necessity of EBPI
project

When
4/21/14

Where
clinic

EBPI project

4/21/14

clinic

leader
Site director
Medical director

4/21/14

clinic

Plan for collection of data: (see Data Collection Plan form)
Administered LARC project site provider opinion survey prior to beginning presentation to assess
attendees’ attitudes about LARC prior to the intervention
DO: Test the changes.
Was the cycle carried out as planned?
Presentation and introduction of toolkit was carried out as planned
Responses were less enthusiastic than anticipated-very few questions asked, when EBPI project leader
asked what components of the toolkit attendees could picture themselves using one provider said “I just
need time to digest this,” and no one else responded.
Thoughts-may have given fewer resources in toolkit
Medical director stated during the roll-out meeting that he wanted the scripting limited to providers and
nurses for now due to “medico-legal concerns.” EBPI project leader reiterated that the goal was for no
individual’s bias to create a barrier to the patient’s method choice.
Record data and observations.
What did you observe that was not part of our plan?
Agency overseeing clinic held mandatory staff in-service on STI on 4/23/14. This program included a
presentation on adolescents and LARC which reinforced the material presented on Monday. However,
this also replaced the providers’ administrative time and was cited as the reason they did not look
through the toolkit this week (per EBPI project liaison)
STUDY:
Did the results match your predictions?
Presentation response was less enthusiastic than anticipated
4/23/14 presentation was not anticipated
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Compare the result of your test to your previous performance:
What did you learn?
May be that this group was less enthusiastic due to being asked to “do” something with the material
rather than just opening discussion about LARC
ACT: Decide to Adopt, Adapt, or Abandon.
X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test: Consider pulling out pieces of toolkit to post in relevant locations in
clinic. Will f/u with EBPI project liaison and site director about this.
Adopt: Select changes to implement on a larger scale and develop an implementation plan and
plan for sustainability
Abandon: Discard this change idea and try a different one
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PDSA WORKSHEET
Date of test: 4/28/14Team/project:
5/11/14

Cycle: 2

Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers
Test population: Same
What is the objective of the test?
Increase utilization of toolkit components by posting prescribing algorithms in prominent locations

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
Participant verbal feedback was that they had not used the toolkit and that their habits had not changed.
Continue toolkit utilization and post prescribing algorithms in prominent places in the clinic. Note whether
placing color algorithms where contraceptives are accessed increases utilization of prescribing algorithms
by providers
How will you know that the change is an improvement?
Provider and staff feedback initially, a change in % of LARC prescriptions overall
What driver does the change impact?
Provider disclosure of LARC methods
What do you predict will happen?
Seeing LARC algorithm when accessing other contraceptive methods from contraceptive storage area
will prompt participants to remember the project and counsel about LARC methods
Plan for change or test: who, what, when, where (use back for more detail)

PLAN
Test start date:

List the tasks necessary to complete this
test (what)
1. Continue utilization of toolkit

Target test completion date:
Person
responsible
(who)
clinic providers
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When
4/28/14-5/6/14

Where
clinic

2.Post algorithms in prominent places

Site director

4/28/14-5/6/14

clinic

Plan for collection of data: (see Data Collection Plan form)
Email communication with EBPI project liaison
DO: Test the changes.
Was the cycle carried out as planned?
No- EBPI project liaison indicated that there was no discussion among providers about toolkit or LARCs
this week and they “did not have time” to look at toolkit.
Record data and observations.
What did you observe that was not part of our plan?
See above
STUDY:
Did the results match your predictions?
No. Providers still are not utilizing the toolkit, but may be utilizing the posted algorithms. Providers and
staff are responsive to EBPI project leader’s presence as demonstrated by their verbal engagement
when the EBPI project leader is on site.
Compare the result of your test to your previous performance:
No measurable result, participants still lacking the enthusiasm that was anticipated.
What did you learn?
Clinicians will need additional intervention to affect change
ACT: Decide to Adopt, Adapt, or Abandon.
X
X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test:
Adopt: Select changes to implement on a larger scale and develop an implementation plan and
plan for sustainability – Per discussion with site director, will plan more “face time” from EBPI
project leader. Algorithms and reminder notes strategically placed, biweekly emails to EBPI
project liaison
Abandon: Discard this change idea and try a different one
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PDSA WORKSHEET
Date of test: 5/12/14Team/project:
5/18/14

Cycle: 3

Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers
Test population: Same
What is the objective of the test?
Continue use of prominently placed algorithms, increase “face time” between project leader and
participants to at least once per week and check in with project liaison by email at least once each week.

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
Participant verbal feedback was that they had not used the toolkit and that their habits had not changedthis remains unchanged from last week. However, participants acknowledged presence of algorithms.
EBPI project leader noticed that participants are eager to talk, but do not utilize the toolkits and have
not used the “parking lot” which is a notebook in the break room where participants can give anonymous
feedback about the EBPI project.
How will you know that the change is an improvement?
Participants will increase percentage of LARC methods prescribed.
What driver does the change impact?
Provider disclosure and prescribing of LARC methods
What do you predict will happen?
Anticipate that the EBPI project leader’s presence will keep EBPI project in participants’ minds and
help to clarify misperceptions verbally through organically occurring conversation since participants are
not using toolkits.
Plan for change or test: who, what, when, where (use back for more detail)
Continue to encourage use of toolkit, increase participant awareness of toolkit by posting algorithms in
prominent places and increasing face time with EBPI project coordinator to twice weekly.

PLAN
Test start date:

Target test completion date:
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List the tasks necessary to complete this
test (what)
1. Continue to encourage utilization of
toolkit
2.
Continue choice project LARC insertion
algorithms in prominent locations
3.increase on-site presence of EBPI
project coordinator to twice weekly

Person
responsible
(who)
Providers

Site director

EBPI project
leader

When
5/15/14-EBPI
project
completion
5/15/14-EBPI
project
completion
5/15/14-EBPI
project
completion

Where
clinic

clinic

clinic

Plan for collection of data: (see Data Collection Plan form)
Weekly visit to site and weekly email communication with EBPI project liaison
DO: Test the changes.
Was the cycle carried out as planned?
Yes
Record data and observations.
What did you observe that was not part of our plan?
One clinician uses a different insertion algorithm and looks it up online each time she wants to utilize it.
This algorithm is from reproductiveaccess.org
STUDY:
Did the results match your predictions?
No
Compare the result of your test to your previous performance:
What did you learn?
Clinicians will continue to need additional intervention to affect change. EBPI project leader will
examine contraceptive algorithms at reproductiveaccess.org to determine consistency with toolkit
algorithms.
ACT: Decide to Adopt, Adapt, or Abandon.
X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test: examine contraceptive algorithms at reproductiveaccess.org

X

Adopt: Select changes to implement on a larger scale and develop an implementation plan and
plan for sustainability – Per discussion with site director, will plan more “face time” from EBPI
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project leader. Algorithms and reminder notes strategically placed, biweekly emails to lead
clinician
Abandon: Discard this change idea and try a different one
PDSA WORKSHEET
Cycle: 4
Date of test: 5/19/14Team/project:
5/25/14
Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers

Test population: Same

What is the objective of the test?
Continue use of prominently placed algorithms, increased “face time” with EBPI project coordinator to
twice weekly, add “quick start algorithm” and “switching contraceptive methods” algorithm from the
Reproductive Health Access Project (http://www.reproductiveaccess.org/) because one of the providers
shared that she refers to these algorithms online as needed because she had become accustomed to
doing so prior to the introduction of the toolkit. These algorithms were not added to the provider resource
notebooks, but were posted in the providers’ workspace per this provider’s preference.

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
Reproductive Access algorithms were added to provider workspace as one provider is using these
preferentially already and the information is consistent with the toolkit and the goals of the EBPI project.
How will you know that the change is an improvement?
Participants will prescribe an increased percentage of LARC methods
What driver does the change impact?
Provider disclosure and prescribing of LARC methods
What do you predict will happen?
Seeing LARC algorithm when accessing other contraceptive methods from contraceptive storage area
will prompt participants to remember the EBPI project and counsel about LARC methods-this remains
unchanged.
Anticipate that EBPI project leader presence will keep EBPI project in participants’ minds and help to
clarify misperceptions verbally through organically occurring conversation since participants are not using
resource guides. Having reproductive access algorithms posted (rather than having to look them up
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online with each use) will increase the potential for LARC disclosure/prescribing at least for the one
provider who prefers those algorithms.
Plan for change or test: who, what, when, where (use back for more detail)
Add algorithms from reproductive access.org to existing posted algorithms to reinforce concepts.

PLAN
Test start date:

Target test completion date:
Person
responsible
(who)
Providers

When
5/15/14-5/21/14

Where
clinic

2.
Continue choice project LARC insertion
algorithms in prominent locations
3.increase on-site presence of EBPI
project leader to twice weekly

Site director

5/15/14-5/21/14

clinic

EBPI project

5/15/14-5/21/14

clinic

4. Add Reproductive Access algorithms to
provider workspace

EBPI project

5/21/14-6/2/14

clinic

List the tasks necessary to complete this
test (what)
1. Continue utilization of toolkit

leader

leader

Plan for collection of data: (see Data Collection Plan form)
Email communication with lead clinician, visit to site. Record prescribing data for first month (collected by
clinic nurse)
DO: Test the changes.
Was the cycle carried out as planned?
Yes
Record data and observations.
Providers and staff responded positively to increased face-time. Began to spontaneously socialize with
the EBPI project leader and discuss their beliefs and prescribing habits more freely.
What did you observe that was not part of our plan?
Providers are still not utilizing the toolkit. Verbally they indicate that they perceive themselves already
prescribing LARC methods at every opportunity and don’t see a need to increase.
At this site providers order DMPA for a year at each annual exam and the follow-up visits ( every 11-15
weeks) are nurse visits in which the patient does not see a provider.
STUDY:
Did the results match your predictions?
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No, prediction was that providers would be more enthusiastic about change once they had motivating
information.
Compare the result of your test to your previous performance:
Providers are more verbally engaged with the EBPI project leader, but “buy-in” remains questionable.
What did you learn?
Face time is critical to establish the EBPI project, but cannot be part of the sustainability plan.
Clinicians will need additional intervention to affect change
ACT: Decide to Adopt, Adapt, or Abandon.
X

X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test:
Add: training for nurses who administer 3 of the 4 DMPA visits per patient per year.
Adopt: Select changes to implement on a larger scale and develop an implementation plan and
plan for sustainability – Per discussion with site director, will continue more “face time” from the
EBPI project leader. Algorithms and reminder notes strategically placed, biweekly emails to
lead clinician.
Abandon: Discard this change idea and try a different one

83

PDSA WORKSHEET
Date of test: 5/26/14Team/project:
6/8/14

Cycle: 5

Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers
Test population: Same
What is the objective of the test?
Work with nursing staff (3 nurses) to deliver LARC information at follow-up DMPA injections. At this site
providers order DMPA for a year at each annual exam and the follow-up visits (every 11-13 weeks) are
nurse visits in which the patient does not see a provider.

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
Train RNs and LPNs to counsel at DMPA injection visits using same information from initial training
tailored to the RN/LPN role at this site and focusing on LARC as an alternative to DMPA.
How will you know that the change is an improvement?
Participants will increase the percentage of LARC prescriptions
What driver does the change impact?
Provider disclosure and prescribing of LARC methods
What do you predict will happen?
RNs and LPNs will use DMPA injection visits to counsel about LARC. Patients will then request LARC
which will be measured by an increase in LARC prescriptions.
Plan for change or test: who, what, when, where (use back for more detail)
Train RNs and LPNs to counsel at DMPA injection visits using same information from initial training
tailored to the RN/LPN role at this site and focusing on LARC as an alternative to DMPA.

PLAN
Test start date:

Target test completion date:
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Person
responsible
(who)
Providers

When
5/15/14-5/21/14

Where
clinic

2. Continue choice project LARC insertion
algorithms in prominent locations
3.increase on-site presence of EBPI
project coordinator to twice weekly

Site director

5/15/14-5/21/14

clinic

EBPI project

5/15/14-5/21/14

clinic

4. Add Reproductive Access algorithms to
provider workspace

EBPI project

5/21/14-6/2/14

clinic

5. Train RNs and LPNs to counsel about
LARCs at DMPA visits.

EBPI project

6/2/14-6/9/14

clinic

List the tasks necessary to complete this
test (what)
1. Continue utilization of toolkit

leader

leader

Leader
RNs
LPNs

Plan for collection of data: (see Data Collection Plan form)
Email communication with lead clinician, visit to site. Record prescribing data (collected by nurse)
DO: Test the changes.
Was the cycle carried out as planned?
No, two of the three nurses were out sick during the scheduled time, so EBPI project leader met with
each nurse individually over several weeks.
Record data and observations.
All three nurses verbally expressed interest in the EBPI project and in educating patients at f/u DMPA
visits. Two nurses stated that the information was not a change from how they already counseled at
these visits. One nurse stated that she had not previously known that a LARC could be initiated prior to
the next scheduled DMPA injection.
What did you observe that was not part of our plan?
Providers are still not utilizing the toolkit. Verbally they indicate that they perceive themselves already
prescribing LARC methods at every opportunity and don’t see a need to increase.
See above
STUDY:
Did the results match your predictions?
Fewer nurses were educated than planned in first week so cycle was extended to two weeks.
Compare the result of your test to your previous performance:
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What did you learn?
Need to continue to be available for face time and follow up as needed to adapt to clinic schedule and
staffing.
ACT: Decide to Adopt, Adapt, or Abandon.
X

X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test: Share results from first 4 weeks of EBPI project, Give positive
feedback about changes noted in hopes that this will increased awareness of and enthusiasm
about EBPI project.
Adopt: continue training anyone who administers DMPA at this site. Currently all such
personnel have been trained.
Abandon: Discard this change idea and try a different one
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PDSA WORKSHEET
Date of test: 6/9/14Team/project:
6/29/14

Cycle: 6

Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers
Test population: Same
What is the objective of the test?
Continue as above from previous weeks. Added feedback that LARC prescribing had increased for
adolescents and young women and posed two questions to prescribers by email. Questions were
developed by the site director based on her knowledge of the individuals involved:
1) Why do you think LARC prescribing has increased?
2) What have you done to contribute to the increase?

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
Continue as above from previous weeks. Added feedback that LARC prescribing had increased for
adolescents and young women and posed two questions to prescribers by email:
3) Why do you think LARC prescribing has increased?
4) What have you done to contribute to the increase?
Continue as above from previous weeks.
How will you know that the change is an improvement?
Participants will prescribe an increased percentage of LARC methods
What driver does the change impact?
Provider disclosure and prescribing of LARC methods
What do you predict will happen?
Positive feedback about first month’s data may renew interest in the EBPI project. Reflecting on
questions posed may increase provider “buy in” for the EBPI project.
Plan for change or test: who, what, when, where (use back for more detail)
Post positive feedback to participants by email and elicit their feedback to two questions (see above)
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PLAN
Test start date:

Target test completion date:
Person
responsible
(who)
Providers

When
5/15/14-5/21/14

Where
clinic

2.
Continue choice project LARC insertion
algorithms in prominent locations
3.increase on-site presence of EBPI
project coordinator to twice weekly

Site director

5/15/14-5/21/14

clinic

EBPI project

5/15/14-5/21/14

clinic

4. Add Reproductive Access algorithms to
provider workspace

EBPI project

5/21/14-6/2/14

clinic

5.
Give LARC prescribing feedback to
providers and pose questions about why
change might have occurred.
6. Post positive feedback (per “buy-in”
article),

EBPI project

6/9/14-6/29/14

clinic

6/9/14-6/29/14

clinic

List the tasks necessary to complete this
test (what)
1. Utilization of toolkit

leader

leader

leader

EBPI project
leader

Plan for collection of data: (see Data Collection Plan form)
Email communication with lead clinician, visit to site. Record prescribing data (collected by nurse)
DO: Test the changes.
Was the cycle carried out as planned?
Yes
Record data and observations.
One provider she did alter her counseling about LARC to discuss LARC methods first. Other providers
responded verbally and by email that they did not know why a change was observed, that they did not do
anything to affect the change, and that it may have been due to chance. One participant wrote, “I’m not
sure why there has been a difference. Maybe everyone feels more comfortable discussing LARCs with
our patients since we received the education from you? Or maybe it’s a coincidence? It’s hard to say. But
it’s a good thing! I think the only thing that has changed with my practice is that when I list contraceptive
options; I start with the LARCs and work my way down. I used to start with the pills because that’s what
most patients are most familiar with.“
STUDY:
Did the results match your predictions?
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It was predicted that providers would be able to verbalize ways they had contributed to change and that
awareness of a positive change would provide motivation to continue to improve. One provider was able
to articulate a way she had changed and possibly contributed to the improvement. The other two
providers wrote that they did not perceive a need for change and thought the observed change was due
to chance.
Compare the result of your test to your previous performance:
What did you learn?
Clinicians continue to need additional intervention to affect change
ACT: Decide to Adopt, Adapt, or Abandon.
X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test:

X

Adopt: Continue as is, Assemble data from the second four weeks of the EBPI project and
continue to solicit feedback from participants.
Abandon: Discard this change idea and try a different one
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PDSA WORKSHEET
Date of test: 6/30/14Team/project:
7/13/14

Cycle: 7

Overall team/project aim: Increase percentage of contraceptive prescriptions written for 15-25 year olds
that are LARC methods from 6% to 20% over 12 weeks
Overall population: clinic providers

Test population: Same

What is the objective of the test?
The plan was to compile and evaluate data from the second 4 weeks of the EBPI project and
present these to participants to generate continuing momentum and possibly increase buy-in for
the EBPI project. During data compilation the EBPI project leader realized that clinicians
were generating a new DMPA prescription with every injection rather than generating one
prescription yearly with refills. Because data was being counted based on the number of
prescriptions generated for each method type, this was essentially quadrupling the number of
prescriptions for DMPA. The EBPI project leader and the data collector reexamined the
numbers, altering the criteria to reflect prescriptions generated during a visit with a clinician
only. At this point overall data for the entire EBPI project period was shared with each
participant. At the end of cycle 7 participants were once again congratulated for the positive
change in prescribing for women aged 15-25 and were asked to complete the LARC project
site provider opinion survey (identical to the one given before the initial teaching) in order to
evaluate any changes in opinion about LARC methods.

Plan

Do

Act

Study

PLAN:
Briefly describe the test:
Continue as above from previous weeks
How will you know that the change is an improvement?
Participants will prescribe more LARC methods
What driver does the change impact?
Provider disclosure and prescribing of LARC methods
What do you predict will happen?
Positive data will increase buy-in.
Plan for change or test: who, what, when, where (use back for more detail)
Share overall EBPI project data with participants and elicit feedback
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PLAN
Test start date:

Target test completion date:
Person
responsible
(who)
Providers

When
5/15/14-5/21/14

Where
clinic

2. Continue choice project LARC insertion
algorithms in prominent locations
3.increase on-site presence of project
coordinator to twice weekly

Site director

5/15/14-5/21/14

clinic

EBPI project

5/15/14-5/21/14

clinic

4. Add Reproductive Access algorithms to
provider workspace

EBPI project

5/21/14-6/2/14

clinic

5. Give LARC prescribing feedback to
providers and pose questions about why
change might have occurred.
6. Train other nurses in LARC counseling

EBPI project

6/9/14-6/15/14

clinic

June/July 2014

clinic

List the tasks necessary to complete this
test (what)
1. Utilization of toolkit

leader

leader

leader

EBPI project
leader

7. Share overall project outcomes

EBPI project

July, 2014

leader and all
participants
Plan for collection of data: (see Data Collection Plan form)
Email communication with lead clinician, visit to site. Record prescribing data (collected by nurse)
DO: Test the changes.
Was the cycle carried out as planned?
Yes
Record data and observations.
What did you observe that was not part of our plan?
Providers are still not utilizing the written materials. Verbally participants indicate that they perceive
themselves already prescribing LARC methods at every opportunity and don’t see a need to increase.
Leadership has not responded to inquiry about EBPI project alteration and continuation.
See above
STUDY:
Did the results match your predictions?
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Predicted that leadership would be more eager to adapt and continue EBPI project due to funding that
is dependent on LARC prescribing numbers and eagerness to be a leader in the public health
community. Did not anticipate that funding cuts from other sources would alter staffing during this cycle
and going forward thereby distracting the leadership with other issues.
Compare the result of your test to your previous performance:
What did you learn?
Face time is critical to establish the EBPI project, but cannot be part of the sustainability plan.
Clinicians will need additional intervention to affect change
ACT: Decide to Adopt, Adapt, or Abandon.
X

Adapt: Improve the change and continue testing plan.
Plans/changes for next test:

X

Adopt: Collect final data for dissemination
Abandon: Discard this change idea and try a different one
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Appendix H
CHOICE LARC Insertion Timing Algorithm
Advanced Practitioner Resources: Provision Guides
modification date:
August 1, 2013
content:
LARC Insertion Timing Algorithm
Overview
This document describes the algorithm used by CHOICE in determining LARC insertion
timing.
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